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A B S T R A C T
Background
Ingrowing toenails are a common problem in which part of the nail penetrates the skinfold alongside the nail, creating a painful area.
Different non-surgical and surgical interventions for ingrowing toenails are available, but there is no consensus about a standard first-
choice treatment.
Objectives
To evaluate the effects of non-surgical and surgical interventions in a medical setting for ingrowing toenails, with the aim of relieving
symptoms and preventing regrowth of the nail edge or recurrence of the ingrowing toenail.
Search methods
We updated our searches of the following databases to January 2010: the Cochrane Skin Group Specialised Register, CENTRAL in
The Cochrane Library, MEDLINE, and EMBASE. We also updated our searches of CINAHL, WEB of SCIENCE, ongoing trials
databases, and reference lists of articles.
Selection criteria
Randomised controlled trials of non-surgical and surgical interventions for ingrowing toenails, which are also known by the terms
’unguis incarnatus’ and ’onychocryptosis’, and those comparing postoperative treatment options. Studies must have had a follow-up
period of at least one month.
Data collection and analysis
Two authors independently selected studies, assessed methodological quality, and extracted data from selected studies. We analysed
outcomes as risk ratios (RR) with 95% confidence intervals (CI).
Main results
This is an update of the Cochrane review ’Surgical treatments for ingrowing toenails’. In this update we included 24 studies, with a
total of 2826 participants (of which 7 were also included in the previous review). Five studies were on non-surgical interventions, and
19 were on surgical interventions.
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The risk of bias of each included study was assessed; this is a measure of the methodological quality of several characteristics in these
studies. It was found to be unclear for several items, due to incomplete reporting. Participants were not blinded to the treatment they
received because of the nature of the interventions, e.g. surgery or wearing a brace on the toe. Outcome assessors were reported to be
blinded in only 9 of the 24 studies.
None of the included studies addressed our primary outcomes of ’relief of symptoms’ or ’regrowth’, but 16 did address ’recurrence’.
Not all of the included studies addressed all of our secondary outcomes (healing time, postoperative complications - infection and
haemorrhage, pain of operation/postoperative pain, participant satisfaction), and two studies did not address any of the secondary
outcomes.
Surgical interventions were better at preventing recurrence than non-surgical interventions with gutter treatment (or gutter removal),
and they were probably better than non-surgical treatments with orthonyxia (brace treatment).
In 4 of the 12 studies in which a surgical intervention with chemical ablation (e.g. phenol) was compared with a surgical intervention
without chemical ablation, a significant reduction of recurrence was found. The surgical interventions on both sides in these comparisons
were not equal, so it is not clear if the reduction was caused by the addition of the chemical ablation.
In only one study, a comparison was made of a surgical intervention known as partial nail avulsion with matrix excision compared to
the same surgical intervention with phenol. In this study of 117 participants, the surgical intervention with phenol was significantly
more effective in preventing recurrence than the surgical intervention alone (14% compared to 41% respectively, RR 0.34, 95% CI
0.17 to 0.69).
None of the postoperative interventions described, such as the use of antibiotics or manuka honey; povidone-iodine with paraffin;
hydrogel with paraffin; or paraffin gauze, showed any significant difference when looking at infection rates, pain, or healing time.
Authors’ conclusions
Surgical interventions are more effective than non-surgical interventions in preventing the recurrence of an ingrowing toenail.
In the studies comparing a surgical intervention to a surgical intervention with the application of phenol, the addition of phenol is
probably more effective in preventing recurrence and regrowth of the ingrowing toenail. Because there is only one study in which the
surgical interventions in both study arms were equal, more studies have to be done to confirm these outcomes.
Postoperative interventions do not decrease the risk of postoperative infection, postoperative pain, or healing time.
P L A I N L A N G U A G E S U M M A R Y
Treatments for ingrowing toenails
Ingrowing toenails are a common problem and occur when the edge of the nail grows into flesh at the side of the nail, causing a painful
injury. This punctured skin can become inflamed and infected.
This is an update of the Cochrane review ’Surgical treatments for ingrowing toenails’. We have broadened the scope of this review to
include all types of treatment for ingrowing toenails. As well as including non-surgical treatments for ingrowing toenails, we have also
looked at surgical interventions with pre- and postoperative interventions to reduce postoperative complications.
We included 24 randomised controlled trials, with a total of 2826 participants, and our aim was to determine which is themost effective
treatment.
By comparison with non-surgical interventions, surgical interventions are more effective in preventing the recurrence of an ingrowing
toenail.
We found that none of postoperative treatments used, such as antibiotics or manuka honey; povidone-iodine with paraffin; hydrogel
with paraffin; or paraffin gauze, reduced the risk of postoperative infection or postoperative pain, or gave a shorter healing time.
Different non-surgical and surgical interventions for ingrowing toenails are available, but there is no agreement about a standard first-
choice treatment.
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B A C K G R O U N D
Description of the condition
Ingrowing toenails, also known as ’onychocryptosis’ or ’unguis in-
carnatus’, are a common problem among the general population.
Most commonly, the big toe is involved, but it may also involve
the lesser toes (DeLauro 2004). Ingrowing toenails occur when
the periungual skin (around the nail) is punctured or traumatised
by one of the distal angles of the nail plate. This results in a cycle
of invasion by foreign bodies, which is sometimes followed by in-
fection with signs of inflammation and then repair processes. The
person develops a painful and draining lesion, with the forma-
tion of granulation tissue at the side of the puncture (Heidelbaugh
2009). These symptoms cause a great deal of discomfort, and they
often have an impact on everyday activities (Yang 2008).
Based on clinical experience, a number of causes have been sug-
gested, including improper trimming of the nail, tearing nails off,
or wearing constricting footwear (Yang 2008). In barefoot popu-
lations, a lower incidence of onychocryptosis has been found, so
it is assumed that wearing shoes is a possible risk factor (Gunal
2003). It has been suggested that thin and flattened nails increase
the risk of ingrown toenails, but this has never been properly stud-
ied. Other risk factors that may increase the likelihood of ingrow-
ing toenails are diabetes and obesity; as well as cardiac, renal, and
thyroid disorders that may predispose people to lower extrem-
ity oedema (Heidelbaugh 2009). In adolescence, the feet perspire
more often, causing the nail and skin to become soft. This results
in nails that easily split, allowing a part of the nail to pierce the
soft skin. In older people ingrowing nails are more often caused
by a reduced ability to care for their nails (DeLauro 2004).
Epidemiology
The 1990 US National Health Survey reported that ingrown toe-
nails were more common with advancing age, in women, in those
earning less than $10,000 per year, and in those living in the
southern United States. Also, ingrowing toenails are reportedly
less common in black people than in white people in nearly all age
groups (DeLauro 2004). Based on foot type, a higher prevalence
is found in people in which the first toe is shorter than the second
toe. Also, in people in which the first and second toes are equal
in length, but in which the first metatarsal is shorter than the sec-
ond, a higher prevalence is found (Gunal 2003). In a multieth-
nic community-based study about prevalence of foot and ankle
conditions, the most common conditions were toenail disorders
(74.9%), of which 7.4% were ingrown nails. There was no signifi-
cant difference in gender or race/ethnicity (Dunn 2004). Approx-
imately 20% of those presenting to a general practitioner with a
foot problem have an ingrowing toenail (Reyzelman 2000). The
Second Dutch National Survey of General Practice gives a preva-
lence in Dutch general practice of 54/10,000 registered patients
per year, with a peak between 15 and 24 years of age (Westert
2005).
Pathophysiology (natural history)
History and physical examination reveal that the most common
cause of ingrowing toenails is improper trimming of the nail.
Proper toenail trimming involves cutting the nail straight across
(Figure 1). When an attempt is made to round off the corners of
the nails, a barb can be created that anchors itself in the soft tissue
around the nail. As the nail plate grows from the matrix distally,
this barb will penetrate these tissues more deeply. If the person
does not seek care, the condition can become chronic. At the side
of the puncture, local inflammatory processes can lead to enzy-
matic digestion of the offending nail portion. The inflammatory
process can lead to a granuloma, and it can result in permanent
hypertrophy of the nailfold. These additional soft tissue masses
can create new pressures on the periungual tissues, fostering re-
currence of the problem (DeLauro 2004).
3Interventions for ingrowing toenails (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 1. Proper Trimming of the Toenail
Ingrown toenails can be classified into three stages: mild (or stage
I), moderate (or stage II), and severe (or stage III) (Figure 2). Mild
cases are characterised by nail-fold swelling, oedema, erythema,
and pain (with pressure), resulting from the puncture of the skin
by the nail plate. Moderate cases are associated with the same
symptoms as in mild cases, but they also lead to inflammatory
granuloma tissue, accompanied by seropurulent discharge; infec-
tion; and sometimes ulceration of the nail fold. The most severe
cases resemble mild and moderate cases, but they mostly exhibit
chronic inflammation; the formation of epithelialised granulation
tissue; and sometimes marked nail-fold hypertrophy. Indications
for treatment of ingrowing toenails, therefore, include significant
pain or infection or chronic, recurrent inflammation of the nail
fold (DeLauro 2004; Gerritsma-Bleeker 2002).
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Figure 2. The Three Stages of Ingrown Toenails
When an ingrowing toenail is presented to a physician, in almost
all cases it will be treated. In general it is assumed that an ingrowing
toenail is not a self-limiting problem, but it can only be cured
if treated properly. When an ingrowing toenail is left untreated,
stage I will develop into stage II, creating more discomfort, and
it may prevent the person from carrying out their normal daily
activities. Stage II will become a stage III ingrown toenail with no
intervention. This results in an evenmore painful toe and a greater
impact on the person’s daily life. In the literature we found little
information on the complications when an ingrown toenail is left
untreated. We found only one study in which the possibility of
osteomyelitis secondary to an ingrown toenail was described (Cox
1995).
Description of the intervention
A large number of interventions are used for ingrowing toenails.
These can be divided in two major categories:
Non-surgical (or conservative) interventions
Non-surgical (or conservative) interventions aim to relieve symp-
toms, prevent the ingrown toenail getting worse, help cure the
problem, and prevent recurrence (e.g. in time, repenetration of the
nail fold leads again to clinical symptoms). Non-surgical interven-
tions are most likely to be of use when the ingrowing toenail is at a
mild or moderate stage of development (stage I and stage II). Gut-
ter treatment (plastic) and orthonyxia are explained below. Many
other non-surgical or conservative interventions are also available,
for example, soaking the toe in warm water or placing a cotton
wisp under the ingrowing nail edge (Heidelbaugh 2009).
Surgical interventions
Surgical interventions aim to remove the troublesome part of
the nail (in combination with matrix destruction), thus, relieving
symptoms and preventing regrowth of the nail, which prevents re-
currence. Surgical interventions are most likely to be of use when
the ingrowing toenail is at a more severe stage of development
(stage II and stage III).
Recurrence is defined as repenetration of the nail fold over time,
resulting in a repeat of clinical symptoms.
Regrowth is defined as when the (part of the) nail that has been
operatively removed has returned.
There are a lot of different surgical interventions. Almost every
surgical intervention aims to remove the troublesome part of the
nail and destroy the underlying matrix so that there is a small risk
of recurrence. The techniques used nowadays are mostly modifica-
tions of the techniques originally described by Winograd, Zadik,
and Ross (Ross 1969; Winograd 1929; Zadik 1950). The nomen-
clature in the classification of the interventions is based on the
description of the technique, instead of the names of the inventor
of the technique.
The following techniques and combinations of techniques are used
as surgical interventions (see below for explanations).
1. radical excision of the nail fold (also known as ’Vandenbos
procedure’)
2. rotational flap technique of the nail fold
3. wedge excision, wedge segmental excision, or wedge
resection (also known as ’Winograd’)
i) combined with application of a caustic liquid, like
phenol (Ph) or sodium hydroxide (sod)
4. total nail avulsion
i) combined with total (chemical or surgical) excision of
the matrix (also known as ’Zadik’)
5. partial nail avulsion (PNA, also known as ’Ross’)
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i) combined with surgical (partial) matricectomy
(removing the matrix of the nail)
ii) combined with chemical (partial) matricectomy with
phenol (Ph) or sodium hydroxide (sod)
iii) combined with physical (electrofulguration)
matricectomy (electrofulguration is a method of electrosurgery
used to produce superficial desiccation of tissue)
How the intervention might work
Non-surgical interventions
Figure 3 relates to the following three treatments.
Figure 3. Three Non-surgical Interventions
Gutter treatment
With gutter treatment (also known as gutter removal or splint
technique), a small vinyl or plastic tube slit from top to bottom
with one end diagonally cut is placed over the ingrowing nail side,
separating the nail from the nail wall, and, thus, preventing it from
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growing further into the skin. The tube can be affixed with tape
or with sutures (Schulte 1998).
Orthonyxia
Orthonyxia (also known as brace treatment) is an intervention in
which a small metal brace is placed on the nail after the trouble-
some part of the nail is removed. The metal brace has an omega
shape on its highest level and U-shaped hooks on both sides. These
hooks are placed around both edges of the nail, then the brace is
put under tension, placed on the dorsum of the nail, and attached
with gel. The aim of this intervention is relieving nail pressure
on the soft tissue and correcting the nail bed deformity (Larsen
1971).
Band-aid method
With adhesive bandage, the nailfold is pulled away from the nail.
The idea of this technique is that it will reduce the pressure of the
nail on the edge of the nail.
Surgical interventions
The preparation for a surgical procedure is the same for almost
all techniques: The affected toe is cleaned with an antiseptic, like
iodine or alcohol, then a ring block anaesthetic (with lidocaine or
procaine) at the base of the toe is applied. A tourniquet is applied to
prevent excessive bleeding, then one of the following interventions
is carried out. (With the first three techniques, the pressure of the
nailplate on the nailfold is taken away by removing the nailfold.
With the last two techniques, the pressure of the nailplate on the
nailfold is taken away by removing (a part of ) the nailplate.)
Radical excision of the nail fold (no figure)
A surgical blade is inserted vertically between the nail fold and
the edge of the nail until it protrudes through the plantar surface
of the toe. The blade is then pushed in distally, slicing the nail
fold from the toe. The flap is then cut off at the base, leaving a
raw defect, which is covered with a gauze and pressure dressing
(Antrum 1984).
Rotational flap technique (no figure)
A V-shaped area is excised from the proximal nail fold, allowing
rotation of the lateral nail fold to cover the exposed area after
excision. Another downward incision is made on the distal end of
the lateral nail fold. The whole lateral nail fold is then dissected
free and retracted away from the nail bed. This allows for excision
of the ingrown part of the nail plate and the related matrix. The
lateral nail fold flap is then rotated upward and adjusted to the new
size of the nail plate, thereby, achieving anatomical and aesthetic
closure (El-Shaer 2007).
Figure 4 relates to the following three treatments.
7Interventions for ingrowing toenails (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 4. Surgical Interventions
Wedge resection
The wedge resection was first described by Winograd; nowadays,
several modifications are still used. The aim of this technique is to
remove the troublesomepart of the nail and the offendingnail fold.
A small incision in the soft tissue of the nail fold and eponychium
(proximal nailfold) is made. Chiefly by blunt dissection, the soft
tissue is separated from the ingrowing piece of nail until the lateral
edge of the nail is reached. With small pointed scissors the nail
is cut, the incision extending back to the end of the matrix. The
loose piece of nail is retracted and separated from the nail bed.
With a small surgical curette, the matrix and nail bed is destroyed
to prevent recurrence (Winograd 1929).
Total nail avulsion
Total nail avulsion seems to be the easiest way to relieve symptoms.
The whole nail is removed and, if necessary, the granuloma is
excised. This technique can be combined with total excision of
the underlying matrix (Zadik 1950). Excision of thematrix can be
done in two different ways: by excising the matrix (surgical) with
a surgical knife or scraping away the matrix, or by application of a
caustic liquid (chemical), like phenol or sodium hydroxide. These
liquids destroy living cells and so prevent regrowth of the nail and,
thus, recurrence.
Partial nail avulsion
Partial nail avulsion was first described by Ross. Nowadays modi-
fications of his technique are widely used in treating ingrown toe-
nails. The aim of this technique is to remove the troublesome part
of the nail. This is done by cutting down the longitudinal axis of
the nail and removing the troublesome part of the nail using artery
forceps (Ross 1969). This technique, similar to total nail avulsion,
can be used in combination with several other techniques. Those
that are most used are surgical and chemical matricectomy, which
can be done in two different ways: by excising the matrix (surgi-
cal matrix excision (Surg ME)) with a surgical knife or scraping
away the matrix, or by application of a caustic liquid (chemical),
like phenol or sodium hydroxide. These techniques can be used
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separately, but they are also often used together. First the matrix
is scraped away, and then a caustic liquid is applied to destroy the
remaining matrix. Also, electrofulguration can be used as a way to
destroy the underlying matrix and, so, prevent recurrence.
Surgical and chemical matricectomy are both interventions only
performed in addition to a surgical intervention. They are used in
addition to wedge resection, total nail avulsion, and partial nail
avulsion.
For all surgical procedures, the need of a tetanus injection has to
be considered.
Postoperative interventions
Several interventions to reduce postoperative complications are
available. The aim of these interventions is to reduce postoperative
infectionor inflammation. For this review,we found several studies
looking at the following postoperative interventions:
• oral or topical antibiotics before or after a surgical
intervention;
• povidone-iodine with paraffin gauze after surgical
intervention;
• hydrogel with paraffin gauze after surgical intervention;
• paraffin gauze after surgical intervention; and
• manuka honey dressing after surgical intervention.
Why it is important to do this review
There are several interventions for the treatment of ingrowing toe-
nails. It is not clear which interventions give the best results when
looking at recurrence, healing time, postoperative complications
(e.g. infection, bleeding), and satisfaction. Although there is no
consensus about a standard first-choice treatment, most physicians
prefer surgical treatment over non-surgical (conservative) treat-
ment. Surgical interventions are carried out by a wide variety of
healthcare professionals, such as general practitioners, surgeons,
and podiatrists. Non-surgical interventions could be effective for
ingrowing toenails at stage I and maybe even at stage II, but these
interventions are often overlooked, although they could provide a
cost-effective approach in treatment before a surgical intervention
is carried out.
The object of performing a surgical intervention on an ingrowing
toenail is to cure the actual problem and to prevent its regrowth
and recurrence. The object of performing a non-surgical interven-
tion is to cure the problem and prevent recurrence, but not to pre-
vent regrowth. Therefore, the primary outcome measures are the
relief of symptoms and prevention of recurrence and/or regrowth
(including nail spikes/spicules).
In this reviewwe have evaluated different surgical and non-surgical
interventions for ingrowing toenails as well as several interventions
to prevent postoperative complications.
O B J E C T I V E S
To assess the effects of interventions in preventing the recurrence
of ingrowing toenails.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials for the treatment of in-
growing toenails (and for the synonyms ’unguis incarnatus’ and
’onychocryptosis’). Randomised trials comparing postoperative
treatment were also included. The studies must have had a follow-
up period of at least one month.
Types of participants
We includedmen and women of any age who required a treatment
for ingrowing toenail(s).
Types of interventions
We included all treatments for ingrowing toenails, including the
following:
• surgical interventions;
• non-surgical interventions; and
• interventions to reduce postoperative complications.
Types of outcome measures
Primary outcomes
1) Relief of symptoms
2) Recurrence
3) Regrowth (including nail spicules/nail spikes)
Secondary outcomes
1) Healing time
2) Postoperative complications (infection and haemorrhage)
3) Pain of operation/postoperative pain
4) Participant satisfaction
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Search methods for identification of studies
We aimed to identify all relevant randomised controlled trials
(RCTs) regardless of language or publication status (published,
unpublished, in press, or in progress).
Electronic searches
For this update, we searched the following databases up to 20
January 2010:
• the Cochrane Skin Group Specialised Register using the
terms (ingrow* and toenail*) or onychogryphosis or
onychocryptosis or (unguis and incarnatus);
• the Cochrane Central Register of Controlled Trials
(CENTRAL) in The Cochrane Library using the search strategy
in Appendix 1;
• MEDLINE using the strategy in Appendix 2; and
• EMBASE using the strategy in Appendix 3.
A final prepublication search of the above databases was under-
taken on 15 November 2011. We also searched the following
databases up to 15 November 2011:
• CINAHL (Cumulative Index to Nursing and Allied Health
Literature) using the search strategy in Appendix 4; and
• Web of Science using the search strategy in Appendix 5.
Ongoing trials
We searched the following registers of ongoing trials on 15Novem-
ber 2011, using the terms ’ingrown toenail’, ’ingrowing toenail’,
’ingrown toenails’, ’ingrowing toenails’, ’onychocryptosis’, and
’unguis incarnatus’:
• The metaRegister of Controlled Trials (www.controlled-
trials.com).
• The US National Institutes of Health Ongoing Trials
Register (www.clinicaltrials.gov).
• The Australian New Zealand Clinical Trials Registry (
www.anzctr.org.au).
• The World Health Organization International Clinical
Trials Registry platform (www.who.int/trialsearch).
• The Ongoing Skin Trials Register (www.nottingham.ac.uk/
ongoingskintrials).
Searching other resources
We checked the bibliographies of included and excluded studies
for further references to relevant trials.
Data collection and analysis
Selection of studies
In two rounds, two authors independently (AKN and BvW) se-
lected all randomised controlled trials that met the inclusion cri-
teria.
In the first round, we judged whether the study focused on in-
growing toenails and if it was a randomised controlled trial. In
the second round, the same authors judged the follow-up period
for relief of symptoms (one month or more) and if the outcome
measure met our criteria (recurrence, clinical judgement of effect,
participant satisfaction, improvement of symptoms).
Data extraction and management
Two authors (BvW and JCvdW) extracted data independently
using a pre-defined data extraction form. After comparison and
reaching agreement, they entered the data into Review Manager
(RevMan).
Assessment of risk of bias in included studies
Two authors (BvW and JCvdW) critically appraised the studies
independently using a structured form and pre-defined standards.
The studies were assessed on sequence generation, concealment of
allocation, blinding, intention-to-treat analysis, baseline compa-
rability, and completeness of follow-up (see the ’Characteristics of
included studies’ table and ’Risk of bias’ table for each included
study).
Measures of treatment effect
For dichotomous outcomes, we expressed the results as risk ratios
with 95% confidence intervals (Cl). For continuous outcomes, the
results were expressed as mean differences (MD) with 95% CI.
Assessment of heterogeneity
Heterogeneity between the studies was explored using the I² statis-
tic, and if substantial heterogeneity (I² statistic > 50%) existed be-
tween studies for the primary outcome, reasons for heterogeneity
were explored (e.g. using sensitivity analyses to examine the effects
of excluding studies with lower reported methodological quality).
Data synthesis
We examined trials relevant to the focus of this review in greater
detail. We provided a systematic synthesis of included trials, pre-
senting the characteristics of trials and their results.
For studies with a similar type of intervention, we carried out
meta-analyses to calculate a weighted treatment effect across trials
using a random-effects model (DerSimonian and Laird model).
When studies had more than two arms, we conducted pair-wise
analyses. When data from these studies could be pooled, we ad-
justed the size of the study groups by dividing by the number of
arms.
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Sensitivity analysis
We carried out sensitivity analyses in two instances: Where we
were looking at the outcome ’recurrence’ in a comparison of non-
surgical and surgical treatments, we excluded a study without gut-
ter treatment, and where we were looking at the outcome ’post-
operative infection’, we excluded incomparable surgery.
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies.
Results of the search
With our sensitive search we found 982 articles about ingrowing
toenails. For 401 of these, based on the title or abstract, we could
not exclude the possibility that it was a RCT, and we requested a
printed article.
Forty-five studies matched our first selection criteria for possible
inclusion in the review. From these, 24 matched our second selec-
tion criteria and were included in the review, 18 were excluded, 1
study is awaiting assessment, and 2 are ongoing.
Included studies
Twenty-four studiesmet the inclusion criteria, with a total number
of 2826 participants (Anderson 1990; Arista 2006; Beck 1984;
Bos 2006; Dovison 2001; Flores 2006; Gem 1990a; Gem 1990b;
Gerritsma-Bleeker 2002; Greig 1991a; Issa 1988; Kim 2003;
Kruijff 2008; Leahy 1990; McIntosh 2006; Morkane 1984; Perry
1984; Reyzelman 2000; Shaath 2005; Sykes 1988b; Sykes 1988c;
van der Ham 1990; Varma 1983; Wallace 1979b). Three of these
studies were about interventions to reduce postoperative compli-
cations (Dovison 2001;McIntosh 2006; Reyzelman 2000). Please
see the ’Characteristics of included studies’ tables for details.
In the previous review, nine studies were included. In this update, 7
of the 24 included studies were also included in the previous review
(Anderson 1990; Greig 1991a; Issa 1988; Leahy 1990; Morkane
1984; van der Ham 1990; Varma 1983). The two studies that
were part of the previous review, but which we did not include,
were quasi-randomised (Andrew 1979; Tait 1987). Seven of our
24 included studies were found when a search was run (October
2002) prior to publication of the review ’Surgical treatments for
ingrowing toenails’ by Rounding 2003. They were not fully in-
corporated into that review.
In our analysis, we ignored the fact that in some studies participants
could contribute more than one toenail: Firstly, because several
of these studies only reported outcomes per participant, not per
toenail. Secondly, because in most of these studies the number of
participants with more than one contributing toenail was small.
Design
All studies were parallel studies expect for one (Beck 1984), which
was awithin-patient trial. The studies were divided into two, three,
or even four treatment arms: Two studies had four groups (Bos
2006; Perry 1984), and two had three groups (Dovison 2001; Issa
1988).
Sample sizes
The 24 included studies had amedian number of 118 participants.
The samples sizes in the studies varied from 31 to 424 participants
(mean 111).
Setting
All studies were hospital-based.
Participants
Six studies did not report their inclusion and exclusion criteria
(Issa 1988; Kim 2003; Perry 1984; Sykes 1988b; Sykes 1988c;
Varma 1983).
Only two studies reported their inclusion criteria (Leahy 1990;
Shaath 2005). The remaining studies reported both their inclu-
sion and exclusion criteria. Three studies (Greig 1991a; Morkane
1984; van der Ham 1990) excluded participants who had had
previous toenail surgery, and one study (Anderson 1990) only in-
cluded participants who had previously had two or more surgical
procedures on their toenail.
Interventions
Of our 24 included studies examining the effect of a total of 25
different interventions for ingrowing toenails, 5 examined non-
surgical interventions, 16 examined surgical interventions, and 4
examined postoperative interventions.
We found five studies about non-surgical interventions: Two stud-
ies described orthonyxia (Beck 1984; Kruijff 2008), and three
studies described (plastic) gutter treatment (Kim 2003; Perry
1984; Wallace 1979b). We did not find any studies about the
band-aid technique. Three studies compared non-surgical inter-
ventions with surgical interventions (Kruijff 2008; Perry 1984;
Wallace 1979b), one study compared two non-surgical interven-
tions (Beck 1984), and one study compared treatment duration
of a non-surgical intervention (Kim 2003).
We found 18 studies about surgical interventions: 3 compared
any surgical intervention with any other surgical intervention (Bos
2006; Greig 1991a; Perry 1984), 16 added the use of a caustic
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liquid to a surgical intervention and compared this to the surgi-
cal intervention alone (Anderson 1990; Arista 2006; Bos 2006;
Gem 1990a; Gem 1990b; Gerritsma-Bleeker 2002; Greig 1991a;
Issa 1988; Leahy 1990; Morkane 1984; Reyzelman 2000; Shaath
2005; Sykes 1988b; Sykes 1988c; van der Ham 1990; Varma
1983), 1 study added the use of electrofulguration to a surgical
intervention (Flores 2006), and 1 study compared 2 different sur-
gical interventions both with the addition of phenol (Issa 1988).
The shortest follow-up period for recurrence was six months.
Four studies were about different pre- and postoperative inter-
ventions to reduce postoperative complications: Two studies com-
pared pre- and postoperative use of antibiotics following surgi-
cal intervention (Bos 2006; Reyzelman 2000), and the other two
studies compared different postoperative interventions, e.g. dif-
ferent types of gauze (Dovison 2001; McIntosh 2006).
For most comparisons, we found only one study for inclusion. We
found more studies eligible for inclusion for the following com-
parisons: phenol and partial avulsion versus wedge/segmental ex-
cision (five studies), phenol and partial avulsion versus total avul-
sion (two studies), and phenol and partial avulsion versus partial
matrix excision (two studies).
Outcomes
The outcomes measured in these studies varied. Almost all stud-
ies had recurrence as an outcome measure, but seven studies did
not measure recurrence (Arista 2006; Beck 1984; Dovison 2001;
Flores 2006; McIntosh 2006; Reyzelman 2000; Wallace 1979b).
Six studies used infection as an outcomemeasure (Anderson 1990;
Bos 2006; Greig 1991a; Leahy 1990; McIntosh 2006; Reyzelman
2000), and 10 studies measured postoperative pain (Arista 2006;
Flores 2006; Gem 1990a; Gem 1990b; Issa 1988; Kim 2003;
McIntosh 2006; Morkane 1984; Shaath 2005; Wallace 1979b).
Two of these studies measured postoperative pain in the use of
analgesics (Arista 2006; van derHam 1990). Four studies also used
postoperative haemorrhage as an outcome measure (Arista 2006;
Flores 2006; Kruijff 2008; Leahy 1990), 10 studies had healing
time as an outcome measure (Arista 2006; Dovison 2001; Flores
2006; Gem 1990a; Gem 1990b; McIntosh 2006; Perry 1984;
Reyzelman 2000; van der Ham 1990; Varma 1983), and 3 studies
used participant satisfaction as an outcome measure (Anderson
1990; Beck 1984; Greig 1991a).
Some studies used postoperative erythema/redness and exudate
as an outcome measure (Flores 2006; Gerritsma-Bleeker 2002;
Kruijff 2008). Because this is not an objective outcome for infec-
tion, we decided not to include these outcomes in the review. Only
data from studies that reported on infection were included. Also,
Arista 2006, Gerritsma-Bleeker 2002, and Shaath 2005 reported
on healing time, but classified this outcome measure as return-
ing to work or daily activities, returning to hobbies or sports, and
problems with shoe wear. Furthermore, Gerritsma-Bleeker 2002
reported on participant satisfaction, but classified this using a scar,
symptoms, and cosmetic score. Three studies had a loss to follow
up larger than 20% (Gem 1990a; Gem 1990b; Shaath 2005).
We ignored the fact that in seven studies (Gerritsma-Bleeker 2002;
Greig 1991a; Issa 1988; Kruijff 2008;Morkane 1984; Perry 1984;
van der Ham 1990) participants could contribute more than one
toenail, because several of these studies only reported outcomes
per participant, not per toenail. Also, in most of these studies the
number of participants with more than one contributing toenail
was small.
Excluded studies
We excluded 18 studies after the second selection. See the
’Characteristics of excluded studies’ tables for details.
Three studies were not about ingrowing toenails (Boberg 2002;
Foley 1994; Holt 1987); two studies did not compare inter-
ventions (Greig 1991b; Sykes 1988a). Four studies were not
randomised controlled trials (Aksahal 2001; Arai 2004; Schütte
1980; Tada 2004). Seven studies were quasi-randomised (Andrew
1979; Bossers 1992; Bostanci 2007; Burssens 1987; Herold 2001;
Kocyigit 2005; Tait 1987), and one study had a follow-up period
shorter than one month (Córdoba-Fernandez 2008). One study
allocated the participants based on the stage of the ingrown toe-
nail, therefore, introducing bias (Cameron 1981).
Studies awaiting classification
One study is awaiting clarification anddata from the authors (Zaba
2002). Because it is an abstract, themethodology is not adequately
described, and it is not clear whether randomisation was adequate.
Therefore, the study could not be definitely excluded until this is
clarified.
In November 2011, three studies were found (Altinyazar 2010;
Peyvandi 2011; Tatlican 2009), which are awaiting classification.
These will be incorporated in the next update of this review.
Ongoing studies
We found two ongoing studies
(ISRCTN32883274; NCT00641433). We attempted to contact
the authors, but this was not successful. It is unclear if these trials
are complete and whether they have been published.
Risk of bias in included studies
We used the Cochrane Collaborations’ recommended tool for as-
sessing risk of bias (Higgins 2008) and assessed 10 domains for
each study (see the ’Characteristics of included studies’ tables). We
summarised the ’Risk of bias’ tables into the review authors’ judge-
ments about each methodological quality item for each included
study (Figure 5) and a methodological quality graph (Figure 6),
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which gives the review authors’ judgements about each method-
ological quality item presented as percentages across all included
studies.
Figure 5. ’Risk of bias’ table: Review authors’ judgements about each methodological quality item for each
included study.
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Figure 6. Methodological quality graph: Review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
If the method of randomisation was not mentioned in the article,
we contacted the authors. Depending on the additional informa-
tion provided about the method of randomisation, the study was
included or excluded. Studies from authors who did not respond
were still included in the review, although themethod of randomi-
sation was not known.
Allocation
All of the included studies were described as randomised.
We classed all of the studies as at an unclear risk of bias, except
two (Issa 1988; Reyzelman 2000). These used random number
generation, which we classed as at low risk of bias. Nine studies
were randomised using (prearranged) sealed envelopes (Beck 1984;
Bos 2006; Gerritsma-Bleeker 2002; Kruijff 2008; Leahy 1990;
Shaath 2005; van der Ham 1990; Varma 1983; Wallace 1979b),
and one used remote randomisation via a telephone call to an
independent assistant (McIntosh 2006). Twelve studies stated that
they randomised the participants, but they did not specify the
method that was used (Anderson 1990; Arista 2006; Dovison
2001; Flores 2006; Gem 1990a; Gem 1990b; Greig 1991a; Kim
2003; Morkane 1984; Perry 1984; Sykes 1988b; Sykes 1988c).
In three studies, we judged allocation concealment to be satisfac-
tory, and we classed these as at a low risk of bias (Beck 1984;
McIntosh 2006; Shaath 2005).
Blinding
Due to the nature of the interventions, it was not possible to blind
the caregiver to the procedure, so none of the included studies
blinded the caregiver to the intervention. Therefore, we decided
not to include this item in the ’Risk of bias’ assessment. Blinding
the participant to the procedure was done in one study (McIntosh
2006), which we judged to be at low risk of bias; no other included
study attempted to do this.
Nine studies (Anderson 1990; Bos 2006;Gerritsma-Bleeker 2002;
Greig 1991a; Kruijff 2008; Leahy 1990; McIntosh 2006; Shaath
2005; Wallace 1979b) used an independent observer to evaluate
the intervention, which we judged to be at low risk of bias. Four
studies were judged as high risk (Arista 2006; Beck 1984; van
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der Ham 1990; Varma 1983). The other studies did not state if
the evaluation of the intervention was done by an independent
observer, so we classed these as at unclear risk of bias.
Incomplete outcome data
Six of the 24 included studies had no dropouts or withdrawals
andprovided an intention-to-treat analysis (Anderson 1990; Arista
2006; Flores 2006; Kim 2003; Morkane 1984; Wallace 1979b).
Four studies were also low risk because details were given about
the loss to follow up (Beck 1984; Bos 2006; Gerritsma-Bleeker
2002;McIntosh 2006).Two studies provided an intention-to-treat
analysis (Perry 1984; van der Ham 1990), but without clear in-
formation about withdrawals or dropouts.
All 14 other studies were judged as high risk of bias because no
reasons were given. Of these, 2 studies had a loss to follow up
larger than 5%, but less than 10% (Dovison 2001; Varma 1983),
and 6 studies had a loss to follow up of 5% or less (Greig 1991a;
Issa 1988; Kruijff 2008; Leahy 1990; Reyzelman 2000; van der
Ham 1990). In one study, no information was given about the
number lost of follow up (Sykes 1988b). The remaining 5 studies
had losses to follow up of 15% (Perry 1984),19% (Sykes 1988c),
21% (Shaath 2005), 28% (Gem 1990a), and 42% (Gem 1990b),
respectively.
Selective reporting
None of the studies reported about possible selective reporting, so
we classed them all as unclear risk of bias.
Other potential sources of bias
In seven studies, no information was given about the inclusion and
exclusion criteria (Issa 1988; Kim 2003; Leahy 1990; Perry 1984;
Sykes 1988b; Sykes 1988c; Varma 1983) so we classed these as at
high risk of bias. In all other studies, information was given about
inclusion and exclusion criteria, so we classed these as at low risk
of bias.
In two studies, there was a potential risk of other bias (Gerritsma-
Bleeker 2002; Sykes 1988c) (see the ’Characteristics of included
studies’ tables). In four studies, there was a low risk of other bias
because there was no baseline imbalance (Issa 1988; Kruijff 2008;
Leahy 1990;McIntosh 2006), and one other study was also classed
as at low risk of bias (Anderson 1990) because, although there was
an imbalance for sex and age, we judged this to be without risk of
bias.
Effects of interventions
We have discussed the primary and secondary outcomes under the
following comparisons:
• Non-surgical procedures
- Non-surgical interventions with or without pre- or postoperative
treatment versus (vs) non-surgical interventions with or without
pre- or postoperative treatment
• Non-surgical vs surgical procedures
• Surgical procedures
- Chemical ablation and surgery vs surgical procedures
- Different types of surgical procedures
- Chemical ablation and partial avulsion vs chemical ablation and
surgery
- Surgery with electrofulguration vs surgery
• Pre- and postoperative procedures
Primary outcomes
1) Relief of symptoms
2) Recurrence
3) Regrowth (including nail spicules/nail spikes)
None of the included studies addressed our primary outcomes of
’relief of symptoms’ or ’regrowth’, but 16 did address ’recurrence’
(Anderson 1990; Bos 2006; Gem 1990a; Gem 1990b; Gerritsma-
Bleeker 2002; Greig 1991a; Issa 1988; Kim 2003; Kruijff 2008;
Leahy 1990; Reyzelman 2000; Shaath 2005; Sykes 1988b; Sykes
1988c; van der Ham 1990; Varma 1983).
Secondary outcomes
1) Healing time
2) Postoperative complications (infection and haemorrhage)
3) Pain of operation/postoperative pain
4) Participant satisfaction
Not all of the included studies addressed all of our secondary
outcomes, and two studies did not address any of the secondary
outcomes (Sykes 1988b; Sykes 1988c).
Arista 2006, Dovison 2001, Flores 2006, McIntosh 2006, Perry
1984, Reyzelman 2000, van der Ham 1990, and Varma 1983
reported on ’healing time’.
Flores 2006, Greig 1991a, Kruijff 2008, Leahy 1990, and
Reyzelman 2000 reported on ’postoperative infection and haem-
orrhage’.
Arista 2006, Flores 2006, Gerritsma-Bleeker 2002, Issa 1988, Kim
2003, Leahy 1990, McIntosh 2006, Morkane 1984, van der Ham
1990, and Wallace 1979b reported on ’postoperative pain’.
Anderson 1990, Beck 1984, Greig 1991a, and Leahy 1990 re-
ported on ’participant satisfaction’.
Primary outcome:
2) Recurrence
Non-surgical procedures
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Non-surgical interventions with or without pre- or
postoperative treatment vs non-surgical interventions with or
without pre- or postoperative treatment
Therewas no significant difference in the risk of recurrence after 12
months when gutter removal (a non-surgical intervention without
pre- or postoperative treatment) after 3 days was compared with
gutter removal (another non-surgical intervention without pre- or
postoperative treatment) after 2 weeks, in the study by Kim 2003
(RR 0.69, 95% CI 0.12 to 3.83) (see Analysis 1.1).
Non-surgical vs surgical procedures
In three studies, non-surgical interventions were compared to sur-
gical interventions. We chose not to show totals because of the
different nature of the studies.
For 2 of the studies (Perry 1984; Wallace 1979b) in which the
non-surgical intervention with gutter treatment was compared to
surgical treatment (we pooled the 2 control surgical groups), sur-
gical treatment was significantly more effective at preventing re-
currence (RR 0.63, 95% CI 0.47 to 0.85) (see Analysis 2.1). The
bigger study did not find a significant difference (Perry 1984).
In 1 study (Kruijff 2008), there was no significant difference in re-
currence when non-surgical treatment with orthonyxia was com-
pared to surgical treatment (RR 0.89, 95% CI 0.77 to 1.04) (see
Analysis 2.1).
We did a sensitivity analysis for Analysis 2.1; I² statistic was 81%.
Excluding the study without gutter treatment (Kruijff 2008) dra-
matically reduced this (I² statistic = 0%). The total effect for this
subgroup of studies was 0.57 (0.47 to 0.67) (P = 0.00001).
Surgical procedures
Chemical ablation and surgery vs surgical procedures
In 4 of the 12 studies in which a surgical intervention with chem-
ical ablation was compared with a surgical intervention without
chemical ablation, there was a significant reduction of recurrence
in favour of chemical ablation (RR 0.25, 95% CI 0.09 to 0.69 -
Morkane 1984; RR 0.12, 95% CI 0.06 to 0.27 - Greig 1991a; RR
0.09, 95% CI 0.05 to 0.17 - Sykes 1988c; RR 0.26, 95% CI 0.12
to 0.53 - Shaath 2005) (see Analysis 3.1). However, the surgical
interventions on both sides in these comparisons were not equal,
so it is not clear if the reduction was caused by the addition of the
chemical ablation. The observation period of the studies in which
recurrence was reported was 6 to 30 months.
Sykes 1988b only reported on the overall percentage of recurrences
(14%) without specifying this by treatment group.
In one study, a comparison was made with a surgical intervention
with matrix excision, referred to as PNA (partial nail avulsion),
compared to the same surgical intervention with phenol (Bos
2006). The outcome of ’recurrence at one year’ was presented
for the ’no antibiotic’ and for the ’antibiotic’ group. We took
both groups (’no antibiotic’ and ’antibiotic’) together because we
presumed that antibiotic application after the surgical intervention
had no effect on recurrence. In this study (Bos 2006), there were
123 participants, but 6were lost to followup: 5 from the PNAwith
phenol group, leaving 58 participants, and 1 from the PNA-alone
group, leaving 59 participants. PNAwith phenol was significantly
more effective than PNA alone (RR 0.34, 95% CI 0.17 to 0.69)
(see Analysis 3.1).
Different types of surgical procedures
The study by Greig 1991a showed there was no significant differ-
ence in prevention of recurrence when nail edge excision (Surg-
Proc A) was compared with total avulsion of the nail (SurgProc B)
(RR 1.01, 95% CI 0.82 to 1.24) (see Analysis 4.1).
The study by Perry 1984 showed wedge resection (SurgProc A)
was significantly better after 12 months in preventing recurrence
than the more invasive rotational flap technique (SurgProc B) (RR
0.19, 95% CI 0.05 to 0.80) (see Analysis 4.1). Also, radical ex-
cision of the nail fold (SurgProc A) was significantly better after
12 months in preventing recurrence than the rotational flap tech-
nique (SurgProc B) (RR 0.17, 95% CI 0.04 to 0.72) (see Analysis
4.1). There was no significant difference after 12 months in pre-
vention of recurrence between wedge resection (SurgProc A) and
radical excision of the nail fold (SurgProc B) (RR 1.13, 95% CI
0.17 to 7.53) (see Analysis 4.1).
Chemical ablation and partial avulsion vs chemical ablation
and surgery
One study (Issa 1988), in which phenol with partial nail avulsion
(PNA + Ph) was compared to phenol and wedge resection (wedge
+ Ph), found no significant difference in recurrence after 6months
(RR 10.50, 95% CI 0.58 to 190.65) (see Analysis 5.1). Also, no
significant difference was seen after 12 months when sodium hy-
droxide was added to partial nail avulsion (PNA + Sod, recurrence
13%) compared to phenol and partial nail avulsion (PNA + Ph,
recurrence 8%) (RR 0.61, 95% CI 0.24 to 1.57 - Gem 1990a)
(RR 1.35, 95% CI 0.40 to 4.55 - Gem 1990b) (see Analysis 5.1).
Surgery with electrofulguration vs surgery
We did not find any study which addressed our primary outcomes
when surgery with electrofulguration was compared to surgery
alone.
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Pre- and postoperative procedures
There was a significant difference seen after 12 months in recur-
rence in the study by Bos 2006, when partial nail avulsion with
matrix excision and application of antibiotic (PNA + surg ME +
AB) was compared with partial nail avulsion with application of
phenol and antibiotic (PNA + Ph + AB) (RR 9.52, 95% CI 1.29
to 70.11) (see Analysis 7.1) in favour of phenol and antibiotic. In
this comparison, it is likely that the significant difference is due
to the nature of the intervention and not due to the addition of
antibiotics.
In the following comparisons, therewas no significant difference in
recurrence between the twopostoperative procedures: whenpartial
nail avulsion with matrix excision and application of antibiotic
(PNA + surg ME + AB) was compared with partial nail avulsion
with matrix excision (PNA + surg ME) (RR 0.90, 95% CI 0.47
to 1.75) (see Analysis 8.1), when partial nail avulsion with matrix
excision and antibiotic (PNA+ surgME +AB) was compared with
partial nail avulsion with phenol (PNA + Ph) (RR 1.80, 95% CI
0.76 to 4.22) (see Analysis 9.1), and when partial nail avulsion
with application of phenol and antibiotic (PNA + Ph + AB) was
compared with partial nail avulsion with application of phenol
(PNA + Ph) (RR 0.19, 95% CI 0.02 to 1.44) (see Analysis 10.1).
When partial nail avulsion with phenol plus antibiotic (PNA + Ph
+AB)was comparedwith partial nail avulsionwithmatrix excision
(PNA + surg ME), the former intervention was significantly less
likely to result in recurrence at 12 months (RR 0.10, 95% CI 0.01
to 0.67) (see Analysis 11.1).
However, it must be borne in mind with Analysis 7.1 and Analysis
11.1 that it is not likely that a pre- or postoperative intervention
can reduce regrowth or risk of recurrence.
Secondary outcomes
We have addressed these outcomes under the same intervention
headings as before.
1) Healing time
Surgical procedures
Chemical ablation and surgery vs surgical procedure
van der Ham 1990, Perry 1984, and Varma 1983 reported on
healing time, but they provided insufficient data to enable analyses
for this outcome measure. van der Ham 1990 found no significant
difference inmean healing time between partial avulsionwith phe-
nol (PNA + Ph) and wedge excision (2.2 weeks vs 2.5 weeks), and
Varma 1983 also found no significant difference between wedge
excision with and without phenol (2 weeks vs 2 weeks). Perry 1984
found no significant differences in mean healing time for wedge
excision, radical excision of the nailfold, and plantar rotation of
the nailfold.
Surgery with electrofulguration vs surgery
Flores 2006 reported on healing time (healed after 14 days with
oral antibiotics 65% and with local antibiotics 42%), but did not
provide standard deviations; therefore, we could not use the data.
Pre- and postoperative procedures
In the study by Dovison 2001, there was no significant differ-
ence in healing time when comparisons were made between the
postoperative use of gauzes with manuka honey, povidone-iodine
with paraffin, hydrogel with paraffin, or paraffin gauze alone (see
Analysis 7.4).
In the study by Reyzelman 2000, there was no significant dif-
ference in healing time when a surgical intervention (partial nail
avulsion with phenol) with 1 week of antibiotic afterwards (PNA
+ Ph + AB after) was compared with a surgical intervention (PNA
+ Ph) (MD -0.10, 95% CI -0.40 to 0.20) (see Analysis 10.3),
or when surgical intervention with 1 week’s antibiotic in advance
(PNA + Ph + AB advance) was compared with surgical interven-
tion without antibiotic (PNA + Ph) (MD 0.30, 95% CI -0.02 to
0.62) (see Analysis 13.2).
There was a significant difference in healing time in favour of an-
tibiotics after treatment, when surgical intervention with 1 week’s
antibiotic in advance (PNA+Ph+ABadvance)was comparedwith
surgical intervention with 1 week’s antibiotic afterwards (PNA +
Ph +AB afterwards) (MD0.40, 95%CI 0.11 to 0.69) (see Analysis
12.1).
2) Postoperative complications (infection and haemorrhage)
Surgical procedures
Chemical ablation and surgery vs surgical procedure
In 4 studies (Anderson 1990; Bos 2006; Greig 1991a; Leahy
1990), phenol did not significantly increase the postoperative in-
fection rate (RR 1.51, 95% CI 0.53 to 4.34) (see Analysis 3.3).
(In a sensitivity analysis of Analysis 3.3, excluding incomparable
surgery did not reduce the I² statistic.)
In the study by Greig 1991a, no significant difference was found
in postoperative infection between those undergoing nail edge
excision compared to total nail avulsion (RR 3.75, 95% CI 0.16
to 90.00) (see Analysis 4.3).
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For postoperative haemorrhage, 2 studies (Arista 2006; Leahy
1990) showed no significant difference between partial nail avul-
sion and phenol (PNA + Ph) compared to wedge resection and
matrix excision (wedge + surg ME) (RR 1.18, 95% CI 0.08 to
18.24) (see Analysis 3.4), and partial nail avulsion and phenol
(PNA + Ph) compared to partial nail avulsion and matrix excision
(PNA + surg ME) (RR 0.38, 95% CI 0.08 to 1.67) (see Analysis
3.4).
Pre- and postoperative procedures
There was no significant difference in postoperative infection
when partial nail avulsion with matrix excision and antibiotics
(PNA + surg ME + AB) were compared with partial nail avulsion
with phenol and antibiotics (PNA + Ph + AB) in the study by Bos
2006. Nor was there a significant difference in postoperative in-
fection when manuka honey was compared with paraffin-impreg-
nated tulle gras (McIntosh 2006), when hydrogel with paraffin
gauze was compared with paraffin gauze only, or when povidone-
iodine with paraffin gauze was compared with paraffin gauze only
or with hydrogel with paraffin gauze (Dovison 2001) (see Analysis
7.2).
None of the following comparisons in the study by Bos 2006
showed a significant difference in postoperative infection: partial
nail avulsion with matrix excision and antibiotics (PNA + surg
ME + AB) compared with partial nail avulsion with matrix ex-
cision (PNA + surg ME) (RR 0.95, 95% CI 0.55 to 1.65) (see
Analysis 8.2), partial nail avulsion with matrix excision and an-
tibiotics (PNA + surg ME + AB) compared with partial nail avul-
sion with phenol (PNA + Ph) (RR 0.83, 95% CI 0.48 to 1.41)
(see Analysis 9.2), partial nail avulsion with phenol with 1 week’s
antibiotic afterwards (PNA + Ph + AB after) compared with par-
tial nail avulsion with phenol alone (PNA + Ph) (RR 0.90, 95%
CI 0.56 to 1.46) (see Analysis 10.2), or partial nail avulsion with
phenol and antibiotics (PNA + Ph + AB) compared to partial nail
avulsion with matrix excision (PNA + surg ME) (RR 1.04, 95%
CI 0.64 to 1.70) (see Analysis 11.2).
Reyzelman 2000 gave antibiotics before and after the surgical in-
terventions and compared this to giving no antibiotics. When par-
tial nail avulsion with phenol with 1 week’s antibiotic afterwards
(PNA + Ph + AB after) was compared with partial nail avulsion
with phenol alone (PNA + Ph), there was no significant differ-
ence in postoperative infection (RR 0.18, 95% CI 0.01 to 3.61)
(see Analysis 10.2).When partial nail avulsion with phenol with 1
week’s antibiotic in advance (PNA + Ph + AB advance) was com-
pared with partial nail avulsion with phenol alone (PNA + Ph),
there was no significant difference in postoperative infection (RR
0.20, 95% CI 0.01 to 3.98) (see Analysis 13.1).
3) Pain of operation/postoperative pain
Surgical procedures
Chemical ablation and surgery vs surgical procedure
For the outcome ’pain of operation’, there was no significant dif-
ference between partial nail avulsion with application of phenol
(PNA+Ph) compared towedge excision andmatricectomy (wedge
+ surg ME) (RR 0.53, 95% CI 0.05 to 5.58 - Leahy 1990) (see
Analysis 3.2).
When phenol was added to the surgical intervention, there was
significantly less postoperative analgesic used in the phenol group
in the study by van derHam 1990 (RR0.36, 95%CI 0.25 to 0.54)
(see Analysis 3.5). However, there was no significant difference in
postoperative analgesic use in the 2 groups in the study by Arista
2006 (RR 1.27, 95% CI 0.69 to 2.37) (see Analysis 3.5).
There was no significant difference in postoperative pain in the
study by Gerritsma-Bleeker 2002, when partial nail avulsion and
phenol (PNA + Ph) was compared to partial nail avulsion and
matrix excision (PNA + surg ME) (MD 0.40, 95% CI -0.41 to
1.21) (see Analysis 3.6), or in the study by Morkane 1984 when
partial nail avulsion and phenol (PNA + Ph) was compared with
wedge excision and matricectomy (wedge + surg ME) (MD -3.86,
95% CI -14.22 to 6.50) (see Analysis 3.6).
Chemical ablation and partial avulsion vs chemical ablation
and surgery
With regard to the outcome ’postoperative pain’, there was no
significant difference between chemical ablation with phenol and
partial nail avulsion (PNA + Ph) and chemical ablation with phe-
nol and wedge resection (wedge + Ph) (RR 0.98, 95% CI 0.76 to
1.26) (see Analysis 5.2). It is important to bear in mind that these
conclusions are based on the data of one study (Issa 1988). There
was also no significant difference in postoperative pain intensity
after 24 hours in either group (MD -2.70, 95% CI -7.55 to 2.15)
(see Analysis 5.3).
Surgery with electrofulguration vs surgery
The addition of electrofulguration (to destroy the underlying ma-
trix) to a surgical intervention did not significantly reduce post-
operative pain (RR 0.81, 95% CI 0.35 to 1.86) (see Analysis 6.1)
or postoperative haemorrhage (RR 1.08, 95% CI 0.28 to 4.18 -
Flores 2006) (see Analysis 6.2).
Pre- and postoperative procedures
In the study byMcIntosh 2006, there was no significant difference
in postoperative pain between manuka honey dressing compared
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to paraffin-impregnated tulle gras (MD 0.03, 95% CI -0.47 to
0.53) (see Analysis 7.3).
4) Participant satisfaction
Non-surgical procedures
Non-surgical interventions with or without pre- or
postoperative treatment vs non-surgical interventions with or
without postoperative treatment
One study (Beck 1984) looked at participant satisfaction in a
within-patient trial. From after four months of treatment con-
tinued until six months after treatment, there was a significant
difference in favour of orthonyxia (brace treatment). Participant
satisfaction after 6 months follow-up was 60% after orthonyxia
compared to 14% after conservative treatment (RR 4.20, 95% CI
1.82 to 9.77). A forest plot could not be provided because of the
within-patient comparison.
Non-surgical vs surgical procedures
When looking at postoperative haemorrhage, no significant dif-
ferences were seen. However, there is unlikely to be any postoper-
ative haemorrhage with a non-surgical intervention. Kruijff 2008
reported on participant satisfaction, but did not provide a per-
centage of the treated groups. Instead, the study measured this on
a visual analogue scale. Healing time was also reported, but no
standard deviations were provided. Therefore, we did not include
this data.
Surgical procedures
Chemical ablation and surgery vs surgical procedure
There was no significant difference in participant satisfaction in
the study by Anderson 1990 when total avulsion with phenol was
compared with total avulsion and matrix excision (surg ME) (RR
0.40, 95% CI 0.02 to 9.12) (see Analysis 3.7), or in the study by
Greig 1991a in which nail edge excision was compared with total
avulsion (RR 0.94, 95% CI 0.65 to 1.36) (see Analysis 4.2).
D I S C U S S I O N
Summary of main results
Twenty-four studies examined the effect of a total of 25 different
interventions for ingrowing toenails. Five examined non-surgical
interventions, 16 examined surgical interventions, and 4 examined
postoperative interventions.
Although there are no results about recurrence for non-surgical
intervention with orthonyxia (brace treatment), it does lead to
significantly better participant satisfaction than other non-surgi-
cal interventions. Surgical interventions were better at preventing
recurrence than non-surgical interventions with gutter treatment
and probably better than non-surgical treatments with orthonyxia.
However, it is likely that there is a decreased risk of postoperative
complications when a non-surgical intervention is carried out, due
to the less destructive nature of the intervention.
The evidence identified by this systematic review shows that for
surgical interventions, more invasive interventions with phenol
are likely to reduce recurrence more effectively than less invasive
surgical interventions with phenol. In the only study in which a
surgical treatment with phenol was compared to the same surgical
treatment without phenol, the addition of phenol led to signifi-
cantly better results.
When looking at postoperative pain, infection, and haemorrhage,
no statistically significant differences were found, regardless of the
non-surgical interventions performed. We conclude that adding a
pre- or postoperative intervention to a non-surgical intervention is
not effective when looking at postoperative infection rate, postop-
erative pain, and healing time. There was a significant reduction in
healing time in favour of antibiotics given after a surgical interven-
tion (partial nail avulsion with phenol) when this was compared to
antibiotics given before the same surgical intervention. However,
because no significant difference in healing time was found when
the surgical intervention with antibiotics afterwards was compared
with the surgical intervention alone without any antibiotics, this
effect was judged as not clinically relevant (Reyzelman 2000).
Overall completeness and applicability of
evidence
The previous review included nine studies. In our review we in-
cluded 24 studies, of which 7 were also included in the previ-
ous review (Anderson 1990; Greig 1991a; Issa 1988; Leahy 1990;
Morkane 1984; van der Ham 1990; Varma 1983). The two stud-
ies that were part of the previous review, but which we did not
include, were quasi-randomised (Andrew 1979; Tait 1987). We
found seven studies that were published after the date of the last
search (October 2002) for the previous review. Although we found
nine new studies about surgical interventions, the overall conclu-
sions for the effectiveness of surgical interventions did not change.
We found many studies comparing surgical interventions, but we
only found a few studies about non-surgical interventions (Kim
2003; Kruijff 2008; Perry 1984; Wallace 1979b). This is remark-
able, given the fact that non-surgical interventions are thought to
be effective in stage I, and some cases of stage II, ingrown toenails.
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For severe stage II and stage III ingrowing toenails, surgical inter-
ventions are likely to be more effective than non-surgical interven-
tions. However, the studies comparing non-surgical interventions
with surgical interventions did not mention if they distinguished
between different stages of the ingrowing toenail. One can argue
that a stage III ingrown toenail will not benefit from a non-surgical
intervention, e.g. orthonyxia, but a stage I ingrown toenail will.
In this review, the place of non-surgical interventions in the treat-
ment of ingrowing toenails is unclear. There is a lack of evidence
proving the value of non-surgical interventions; therefore, no hard
conclusions can be made about the effect of non-surgical inter-
ventions compared to surgical interventions. Because the studies
made no distinction between different stages of presentation of
ingrowing toenails, it is not possible to make recommendations at
this stage with regard to whether more radical surgical treatments
are needed for more severe disease.
In this review, no conclusions can bemade for short-term outcome
measures, such as relief of symptoms, participant satisfaction, and
postoperative pain. The included studies used different outcome
measures, which makes comparison difficult. Because it is not
possible to make a distinction between the pain/impact caused
by an intervention and the pain/impact of the ingrowing toenail
itself, outcome measures that measure both aspects are needed.
The use of uniform, short-term outcomemeasures, such as healing
time as an objective measurement and participant satisfaction as
a subjective measurement, are needed to give information about
which interventions give adequate relief of symptoms.
Quality of the evidence
The included studies had a median number of 118 participants,
divided into 2, 3, or even 4 treatment arms. The largest study
(Sykes 1988c) had 424 participants divided into 3 treatment arms.
However, due to unsatisfying results in one arm, they decided to
close this arm, which resulted in a high number of participants
in the other arms. The loss to follow up varied between studies,
with the smallest being 1% (Issa 1988) and the largest being 42%
(Gem 1990b).
For only a small proportion of items in the ’Risk of bias’ table,
a high risk of bias could be assigned (Figure 5). This is largely
due to the fact that most studies did not report details on sev-
eral methodological issues and the follow-up period. Blinding the
participant for a non-surgical intervention is difficult; only one
study (McIntosh 2006) blinded the participant. It is not possible
to blind a participant for orthonyxia or gutter treatment, both of
which have to be worn for several days/weeks. We don’t make a
comparison here with surgical interventions.
Potential biases in the review process
Due to our thorough searching efforts, we do not expect that we
missed relevant randomised controlled trials. There are two ongo-
ing studies (ISRCTN32883274; NCT00641433), and four stud-
ies are awaiting classification (Altinyazar 2010; Peyvandi 2011;
Tatlican 2009; Zaba 2002).
Agreements and disagreements with other
studies or reviews
In the previous review (Rounding 2003), the authors decided to
divide recurrence into symptomatic and asymptomatic recurrence.
In this review, we decided not to divide recurrence in this way, but
to use regrowth and recurrence as primary outcomes. We defined
’regrowth’ as growth of the nail after surgical intervention, but
without symptoms; and ’recurrence’ as being new penetration of
the nailfold by the nail, causing symptoms (after an intervention).
However, regrowth is not an appropriate outcome measure for
non-surgical interventions. For example, when comparing a non-
surgical intervention with a surgical intervention, there is no re-
growth because with a non-surgical intervention the troublesome
part of the nail is not removed. Recurrence is a suitable outcome
for non-surgical interventions, but not for postoperative interven-
tions, given the fact that these interventions aim to reduce post-
operative complications and that they (probably) do not have an
impact on the risk of recurrence.
In the former version of the review, it was concluded that phenol-
lisation combined with a simple avulsion was more effective than
the use of more invasive excisional surgical procedures to prevent
symptomatic recurrence at six months or more. This is not found
in this review because the surgical procedures in the comparison
were not comparable. Because the surgical procedures were not
comparable, the other conclusion of the former version of this re-
view cannot be confirmed, which is that the addition of phenol,
when performing a total or partial nail avulsion, dramatically re-
duces the rate of symptomatic recurrence.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Surgical interventions are more effective than non-surgical inter-
ventions with gutter treatment in preventing recurrence of the in-
growing toenail.
In the studies comparing a surgical intervention to a surgical in-
tervention with application of phenol, the addition of phenol is
probably more effective in preventing recurrence and regrowth.
Because there is only one study in which surgical interventions in
both study arms were equal and where the addition of phenol leads
to better results, more studies have to be done to confirm these
outcomes. A more invasive surgical intervention with application
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of phenol is likely to reduce the risk of recurrence more effectively
than a less invasive surgical intervention with the application of
phenol.
Postoperative interventions do not decrease the risk of postopera-
tive infection or postoperative pain, or give a shorter healing time.
This means that there is no evidence to give antibiotics to prevent
postoperative infections.
Implications for research
New trials are needed to determine the place of non-surgical in-
terventions in the treatment of stage I and II ingrowing toenails.
New trials are needed to determine if the addition of chemical
ablation to a surgical procedure gives a reduction of the risk of
recurrence compared to the surgical procedure alone.
New trials should also examine relevant, uniform short-term out-
comes, such as healing time as an objective measurement and par-
ticipant satisfaction as a subjective measurement, as well as the
primary outcome of recurrence or regrowth.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Anderson 1990
Methods This was a randomised controlled trial (UK).
Participants • 31 participants (age range = 15 to 73 years) attending the general surgery
departments of hospitals, who had undergone at least 2 previous surgical procedures
Onychogryphosis was excluded.
Interventions A: zadik (17)
B: phenol and Zadik (14)
Outcomes Outcomes of the trial
1) Symptomatic recurrence
2) Total recurrence after 12 months
3) Postoperative infection after 1 month
4) Participant satisfaction
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk This was unclear.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Low risk There was an imbalance for sex and age,
without risk of bias
Inclusion and exclusion criteria? Low risk Quote: “The study included...”
Quote: “All patients had recurrent...”
Quote: “Onychogryphotic nails were ex-
cluded.”
Outcome assessor blinded?
All outcomes
Low risk After 2 weeks the assessor was not blinded,
but after 1 year the assessor was blinded
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
Low risk All included participants were included in
the final analysis
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Anderson 1990 (Continued)
Withdrawals or dropouts?
All outcomes
Low risk There were no withdrawals or dropouts.
Arista 2006
Methods This was a randomised controlled trial (Mexico).
Participants • 33 participants with 37 ingrown toenails were randomly selected (M/F = 17/16).
Their age was not reported.
Interventions A: partial lateral matricectomy and phenol cauterization (17)
B: partial lateral matricectomy only (16)
Outcomes Outcomes of the trial
1) Postoperative pain
2) Time to heal
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
Inclusion and exclusion criteria? Low risk Quote: “...included onychocryptosis stage
III...”
Quote: “...excluded...”
Outcome assessor blinded?
All outcomes
High risk This was not reported.
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
Low risk All included participants were included in
the final analysis
Withdrawals or dropouts?
All outcomes
Low risk There were no withdrawals or dropouts
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Beck 1984
Methods This was a randomised controlled trial (Denmark).
Participants • Participants (36) with bilateral unguis incarnatus
Interventions A: conservative treatment (35)
B: orthonyxia (brace treatment) (35)
Outcomes Outcomes of the trial
1) Participant satisfaction
Notes In this ’within patient’ trial, 36 patients with bilateral ingrowing toenails participated.
Every pair of toes was randomised: 1 toe was treated conservatively; the other with a
brace
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk This was not reported.
Allocation concealment (selection bias) Low risk Third party randomisationwas undertaken
using prearranged closed envelopes
Selective reporting (reporting bias) Unclear risk This was not reported.
Other bias Unclear risk This was not reported.
Inclusion and exclusion criteria? Low risk Quote: “...inclusion bilateral unguis incar-
natus...”
Quote: “Exclusion: impaired...”
Outcome assessor blinded?
All outcomes
High risk This was not reported.
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
High risk Dropouts were not included in the final
analysis.
Withdrawals or dropouts?
All outcomes
Low risk 4/36 participants were not included in the
final analysis, due to different reasons
27Interventions for ingrowing toenails (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bos 2006
Methods This was a randomised controlled trial (Netherlands, Departments of Surgery/Pharma-
cology)
Participants • 123 participants (age range = 9 to 73 years, M/F = 72/45) with ingrowing toenail.
All participants had partial nail avulsion (PNA).
Interventions A: partial nail avulsion (PNA) with excision of the matrix (38)
B: PNA with excision of the matrix and application of antibiotics (22)
C: PNA with application of phenol (37)
D: PNA with application of phenol and application of antibiotics (26)
Outcomes Outcomes of the trial
1) Recurrence after 12 months
2) Infection after 1 week
3) Regrowth/spike formation
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk Third party independent randomisation
was not mentioned.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk No baseline characteristics were given.
Inclusion and exclusion criteria? Low risk Quote: “Patients included had...”
Quote: “Exclusion criteria were...”
Outcome assessor blinded?
All outcomes
Low risk Quote: “All outcomes were assessed by in-
dependent observers who were blinded for
initial treatment.”
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
High risk Not all of the participants were analysed at
the end of the study
Withdrawals or dropouts?
All outcomes
Low risk 6/123 participants were lost to follow up.
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Dovison 2001
Methods This was a randomised controlled trial (Australia, Faculty of Public Health Medicine)
Participants • 42 Participants were included (M/F = 20/22). Age was reported for each
treatment group separately.
Interventions A: paraffin gauze (13)
B: povidone-iodine 10% and paraffin gauze (13)
C: amorphous hydrogel and paraffin gauze (16)
Outcomes Outcomes of the trial
1) Postoperative symptoms
2) Healing time
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
Inclusion and exclusion criteria? Low risk Quote: “Participants were selected...and
Table 1 gives a list of the exclusion criteria.
”
Outcome assessor blinded?
All outcomes
Unclear risk No details were given.
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
High risk 6/42 participants were not included in the
final analysis.
Withdrawals or dropouts?
All outcomes
High risk 6/42 participants were excluded, but no
reason why was given
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Flores 2006
Methods This was a randomised controlled trial (Mexico).
Participants • 33 participants with onychocryptosis were randomly allocated.
Interventions A: surgical partial matricectomy (17)
B: partial matricectomy with electrofulguration (21)
Outcomes Outcomes of the trial
1) Postoperative pain intensity
2) Postoperative oedema, secretion, and bleeding
3) Healing time
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
Inclusion and exclusion criteria? Low risk Quote: “...included when stage II and/or
III...” and “...excluded when stage I or vas-
cular insufficiency...”
Outcome assessor blinded?
All outcomes
Unclear risk No details were given.
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
Low risk All included participants were included in
the final analysis
Withdrawals or dropouts?
All outcomes
Low risk There were no dropouts.
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Gem 1990a
Methods This was a randomised prospective study (UK).
Participants • 219 participants were randomly allocated.
Interventions A: chemical ablation with a 3-minute application of 80% phenol (109)
B: chemical ablation with a 2-minute application of 10% sodium hydroxide (110)
Outcomes Outcomes of the trial
1) Recurrence
2) Time to become pain free
3) Healing time
Notes There was a large loss to follow up: 28%.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
Inclusion and exclusion criteria? Low risk Quote: “Patients were accepted...symp-
toms persisted despite conservative man-
agement.”
Quote: “Patients with systemic or vascular
disease were excluded.”
Outcome assessor blinded?
All outcomes
Unclear risk No details were given.
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
High risk Not all of the participants were analysed.
Withdrawals or dropouts?
All outcomes
High risk 62 participants were lost to follow up
(28%), but no reasons were given
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Gem 1990b
Methods This was a randomised prospective study (UK).
Participants • 203 participants were randomly allocated.
Interventions A: chemical ablation with a 2-minute application of 10% sodium hydroxide (110)
B: chemical ablation with a 1-minute application of 10% sodium hydroxide (93)
Outcomes Outcomes of the trial
1) Recurrence
2) Time to become pain free
3) Healing time
Notes There was a large loss to follow up: 42%.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
Inclusion and exclusion criteria? Low risk Quote: “...patients were accepted...symp-
toms persisted despite conservative man-
agement...”
Quote: “...patients with systemic or vascu-
lar disease were excluded.”
Outcome assessor blinded?
All outcomes
Unclear risk No details were given.
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
High risk Not all of the participants were analysed.
Withdrawals or dropouts?
All outcomes
High risk 85 participants were lost to follow up
(42%), but no reasons were given
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Gerritsma-Bleeker 2002
Methods This was a randomised controlled trial (Netherlands, Department of Orthopaedic
Surgery)
Participants • 60 consecutive participants, but 2 withdrew leaving 58 participants, with a total
of 63 ingrowing toenails (age range = 9 to 76 years, M/F = 30/33)
Interventions A: partial matrix excision (34)
B: phenolization (31)
Outcomes Outcomes of the trial
1) Recurrence after 13 months
2) Postoperative morbidity (pain, wound exudates, scar tissue)
3) Time to complete recovery (wearing shoes, return to normal activities/work)
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk Third party randomisation was not explic-
itly stated.
Selective reporting (reporting bias) Unclear risk This was not reported.
Other bias High risk There was only 1 bilateral procedure in 1
participant.
Inclusion and exclusion criteria? Low risk Quote: “All patientswith ingrowing toenail
of the hallux, who also had...were included.
”
Quote: “Patients with diabetes...excluded.
”
Outcome assessor blinded?
All outcomes
Low risk Quote: “Examinations were done by inde-
pendent observers.”
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
High risk Quote: “Evaluation was oriented to each
procedure separately, so we concentrated
the evaluation of the outcomes on 63 pro-
cedures.”
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Gerritsma-Bleeker 2002 (Continued)
Withdrawals or dropouts?
All outcomes
Low risk In total, 8/60 participants withdrew - 2 be-
cause of personal reasons, and 6 because of
an ineffective intervention
Greig 1991a
Methods This was a randomised controlled trial (Scotland, Hairmyres Hospital Glasgow)
Participants • 204 procedures on 168 participants (age range = 12 to 77 years, M/F = 113/50)
referred to hospital during 1 year and for whom conservative treatment had failed.
Interventions A: nail edge excision (47)
B: total nail avulsion (59)
C: nail edge excision and phenol (57)
Outcomes Outcomes of the trial
1) Symptomatic recurrence
2) Total recurrence after 12 months
3) Postoperative infection after 2 weeks
4) Participant satisfaction
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
Inclusion and exclusion criteria? Low risk Quote: “...included all patients with in-
growing toenails.”
Quote: “Recurrent ingrowing or ony-
chogryphotic toenails were excluded.”
Outcome assessor blinded?
All outcomes
Low risk The first observation was done by the sur-
geon. The final assessment was done by an
independent assessor
Participant blinded?
All outcomes
High risk This was not reported.
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Greig 1991a (Continued)
Intention-to-treat?
All outcomes
High risk 5 participants were lost to follow up and
excluded from the final analysis
Withdrawals or dropouts?
All outcomes
High risk 5/168 participants were lost to follow up,
but no reason was given
Issa 1988
Methods This was a randomised controlled trial (Ireland, Adelaide Hospital)
Participants • 170 procedures on 140 participants (age range = 9 to 54 years, M/F = 2.7:1)
referred from general practitioners and accident and emergency departments were
performed.
Interventions A: phenol (45)
B: winograd (42)
C: phenol and Winograd (53)
Outcomes Outcomes of the trial
1) Recurrence (symptomatic or asymptomatic) after 6 months
2) Pain duration first week
3) Pain intensity (linear pain analogue scale)
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Random number generation...”
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Low risk There was no baseline imbalance.
Inclusion and exclusion criteria? High risk No details were given.
Outcome assessor blinded?
All outcomes
Unclear risk No details were given.
Participant blinded?
All outcomes
High risk This was not reported.
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Issa 1988 (Continued)
Intention-to-treat?
All outcomes
High risk Not all of the included participants were
included in the final analysis
Withdrawals or dropouts?
All outcomes
High risk There were 2/140 participants lost to fol-
low up, but no reasons were given
Kim 2003
Methods This was a randomised controlled trial (Korea, Chosun University Hospital)
Participants • 57 participants were included (M/F = 19/38) and treated with the nail splinting
technique. Age was not reported.
Interventions A gutter is placed over the ingrowing nail side
A: gutter removal after 3 days (28)
B: gutter removal after 2 weeks (29)
Outcomes Outcomes of the trial
1) Recurrence after 12 months
2) Tissue status
3) Pain after 1 and 2 weeks and 1 month
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
Inclusion and exclusion criteria? High risk This was not reported.
Outcome assessor blinded?
All outcomes
Unclear risk No details were given.
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
Low risk All included participants were included in
the final analysis
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Kim 2003 (Continued)
Withdrawals or dropouts?
All outcomes
Low risk There were no dropouts.
Kruijff 2008
Methods This was a randomised controlled trial (Netherlands, Departments of Surgery)
Participants • 105 participants with 109 ingrown toenails (M/F = 73/36, mean age = 25/33
years) were included.
Interventions A: partial matrix excision (58)
B: orthonyxia (51)
Outcomes Outcomes of the trial
1) Recurrence after 12 months
2) Postoperative complications (infection, bleeding) after 1 week
3) Return to normal activities/wearing shoes
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk This was not reported.
Allocation concealment (selection bias) Unclear risk Third party independent randomisation
was not mentioned.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Low risk There was no baseline imbalance.
Inclusion and exclusion criteria? Low risk Quote: “All patients with ingrown toenail.
..”
Quote: “We excluded patients...”
Outcome assessor blinded?
All outcomes
Low risk Examination of long-term outcomes was
done by independent observers who were
unaware which of the procedures had been
carried out
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
High risk Not all included participants were included
in the final analysis
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Kruijff 2008 (Continued)
Withdrawals or dropouts?
All outcomes
High risk 5 participants were lost to follow up - 2 par-
ticipants withdrew. No reasons were given
Leahy 1990
Methods This was a randomised controlled trial (Ireland, Department of Surgery)
Participants • 68 participants (mean age = 24 years in each group) with symptoms for more than
1 month who were referred to hospital over a fixed 6-month period
Interventions A: phenol (32)
B: wedge excision (34)
Outcomes Outcomes of the trial
1) Symptomatic recurrence after 16 months
2) Asymptomatic recurrence after 16 months
3) Postoperative infection
4) Postoperative haemorrhage
5) Degree of pain
6) Participant satisfaction
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk It is not clear if sealed, consecutively num-
bered envelopes were used
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Low risk Gender imbalance does not appear to be
clinically relevant.
Inclusion and exclusion criteria? High risk Inclusion criteria are mentioned, but not
exclusion criteria
Outcome assessor blinded?
All outcomes
Low risk Quote: “...patients were examined by an
independent observer.”
Participant blinded?
All outcomes
High risk This was not reported.
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Leahy 1990 (Continued)
Intention-to-treat?
All outcomes
High risk Not all included participants were included
in the final analysis
Withdrawals or dropouts?
All outcomes
High risk There were 2/68 participants lost to follow
up, but no reasons were given
McIntosh 2006
Methods This was a randomised controlled trial (UK, general hospital setting)
Participants • 100 participants with ingrown toenails older than 16 years were included (M/F =
42/58). Mean age was reported for both groups separately. All participants underwent
toenail surgery.
Interventions A: honey dressing (52)
B: paraffin tulle gras dressing following toenail surgery (48)
Outcomes Outcomes of the trial
1) Pain (visual analogue scale)
2) Time to heal in days
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk This was not reported.
Allocation concealment (selection bias) Low risk Quote: “...a telephone call to an indepen-
dent assistant located outside of the study
setting...”
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Low risk Gender imbalance does not seem to be clin-
ically relevant.
Inclusion and exclusion criteria? Low risk Quote: “Patients who matched the inclu-
sion criteria...”
Quote: “Exclusion criteria were...”
Outcome assessor blinded?
All outcomes
Low risk Quote: “The outcome assessor was blinded
for the intervention.”
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McIntosh 2006 (Continued)
Participant blinded?
All outcomes
Low risk Quote: “The patient was blinded for the
intervention.”
Intention-to-treat?
All outcomes
High risk 13/100 participants were not included in
the final analysis.
Withdrawals or dropouts?
All outcomes
Low risk 6/100 participants were lost to follow up,
and 7/100 participants withdrew because
of non-concordance
Morkane 1984
Methods This was a randomised controlled trial (New Zealand, Christchurch Hospital)
Participants • 107 procedures on 103 participants (M/F = 3.5/1) referred from general
practitioners and accident and emergency departments who have had symptoms for
longer than 2 months.
Participants who had undergone surgery previously were excluded
Interventions A: phenol (54)
B: winograd (53)
Outcomes Outcomes of the trial
1) Recurrence (symptomatic or asymptomatic) after 14 months
2) Pain intensity (linear analogue scale) at 1 week (Wilcoxon Rank Sum Test used)
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk No details were given.
Inclusion and exclusion criteria? Low risk Quote: “Operative treatment...ingrowing
toenail longer than 2 months.”
Quote: “Patients with shorter...treated by
conservative measures.”
Quote: “...previously undergone surgery
were excluded.”
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Morkane 1984 (Continued)
Outcome assessor blinded?
All outcomes
Unclear risk Quote: “Patients were seen at...after treat-
ment.”
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
Low risk There were no withdrawals or dropouts.
Withdrawals or dropouts?
All outcomes
Low risk There were no withdrawals or dropouts.
Perry 1984
Methods This was a randomised controlled trial (UK, Leicester Royal Infirmary)
Participants • 84 participants on whom 135 procedures were performed (age and sex were not
reported).
Interventions A: insertion plastic gutter (33)
B: wedge resection (32)
C: radical excision of the nail fold (36)
D: plantar rotation of the nail fold (24)
Outcomes Outcomes of the trial
1) Recurrence after 12 months
2) Time to heal in weeks (no standard deviations)
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk No baseline characteristics were given.
Inclusion and exclusion criteria? High risk Neither inclusion nor exclusion criteria
were provided.
Outcome assessor blinded?
All outcomes
Unclear risk No details were given.
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Perry 1984 (Continued)
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
Low risk All participants/procedures were included
in the final analysis, although this was not
stated
Withdrawals or dropouts?
All outcomes
High risk 20/84 participants were lost to follow up,
but no reasons were given
Reyzelman 2000
Methods This was a randomised controlled trial (US, Department of Orthopaedics)
Participants • 154 participants were included (M/F = 91/63, mean age = 20/7 years).
Interventions A: 1 week of antibiotics and a chemical (phenol) matricectomy simultaneously (53)
B: antibiotics for 1 week and then a chemical matricectomy (51)
C: chemical matricectomy alone (50)
Outcomes Outcomes of the trial
1) Time to heal in weeks
2) Infection
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...computerized randomisation ta-
ble and variable block randomisation...”
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
Inclusion and exclusion criteria? Low risk Quote: “All subjects had...”
Quote: “Patients with...were excluded.”
Outcome assessor blinded?
All outcomes
Unclear risk No details were given.
Participant blinded?
All outcomes
High risk This was not reported.
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Reyzelman 2000 (Continued)
Intention-to-treat?
All outcomes
High risk 6/154 participants were not included in the
final analysis.
Withdrawals or dropouts?
All outcomes
High risk 6/154 participants were lost to follow up,
but no reasons were given
Shaath 2005
Methods This was a randomised controlled trial (UK, Department of Orthopaedics)
Participants • 105 participants (M/F = 53/30, 22 were lost to follow up, average age = 39.4)
Interventions A: total nail ablation (52)
B: partial nail avulsion with chemical ablation by sodium hydroxide (53)
Outcomes Outcomes of the trial
1) Recurrence
2) Postoperative pain
3) Number of dressings
4) Return to normal shoe wear
5) Return to normal activity and work
Notes There was a large loss to follow up: 21%.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Low risk Quote: “Once a patient...details sent to a
member of staff who was not taking part in
the research. The staff member kept all the
opaque envelopes for the randomization..
.As each envelope was opened the partici-
pant was assigned to a list.”
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
Inclusion and exclusion criteria? Low risk Quote: “...only foot problemswere ingrow-
ing toenails.”
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Shaath 2005 (Continued)
Outcome assessor blinded?
All outcomes
Low risk Quote: “The patient was examined by a
nurse not taking part in the trial.”
Quote: “Final assessment was done by a
midwife who had no training in the treat-
ment of ingrowing toenails.”
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
High risk Analysis was not undertaken using inten-
tion-to-treat.
Withdrawals or dropouts?
All outcomes
High risk There was a 21% loss to follow up.
Sykes 1988b
Methods This was a randomised controlled trial (UK, Department of Surgery)
Participants • 152 participants were included. Age and sex were not reported.
Interventions A: total phenolic ablation
B: total excision of the nail bed (Zadik’s operation)
Outcomes Outcomes of the trial
1) Recurrence
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
Inclusion and exclusion criteria? High risk Neither inclusion nor exclusion criteria
were provided.
Outcome assessor blinded?
All outcomes
Unclear risk No details were given.
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Sykes 1988b (Continued)
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
Unclear risk No details were given.
Withdrawals or dropouts?
All outcomes
High risk There was no description of withdrawals
and/or dropouts.
Sykes 1988c
Methods This was a randomised controlled trial (UK, Department of Surgery)
Participants • 424 participants were included. Age and sex were not reported. The participants
allocated to receive segmental phenolic ablation were added to the participants
presenting to chiropodists. From this common pool, participants were randomly
allocated to surgeons or chiropodists.
Interventions A: nail avulsion (45)
B: segmental phenolic ablation by chiropodist (182)
C: segmental phenolic ablation by surgeon (197)
Outcomes Outcomes of the trial
1) Recurrence after 12 months
Notes Because of preliminary disappointing results in the avulsion group, they stopped assigning
participants to this group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk No details were given.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias High risk Due to unsatisfying results in 1 arm (avul-
sion by chiropodists), investigators decided
to close this arm, which resulted in a higher
number of participants in the other arms
Inclusion and exclusion criteria? High risk Neither inclusion nor exclusion criteria
were provided.
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Sykes 1988c (Continued)
Outcome assessor blinded?
All outcomes
Unclear risk No details were given.
Participant blinded?
All outcomes
High risk No details were given.
Intention-to-treat?
All outcomes
High risk Not all included participants were included
in the final analysis
Withdrawals or dropouts?
All outcomes
High risk 7, 37, and 35 participants were lost to fol-
low up/result not known, but no reasons
were given
van der Ham 1990
Methods This was a randomised controlled trial (Netherlands, Department of General Surgery)
Participants • 249 participants (age range = 3 to 97 years, M/F = 158/91) referred by general
practitioners
Participants who had undergone previous surgery were excluded
Interventions A: phenol (125)
B; wedge excision (124)
Outcomes Outcomes of the trial
1) Recurrence
2) Re-operation required
3) Healing time (no standard deviation reported)
4) Pain relief required
5) Time required off work
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk It is not clear if sealed, consecutively num-
bered envelopes were used
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
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van der Ham 1990 (Continued)
Inclusion and exclusion criteria? Low risk Quote: “Patients with ingrowing toenails
are included.”
Quote: “...excluded if they had recurrence
after previous surgery.”
Outcome assessor blinded?
All outcomes
High risk The outcome assessors were not blinded.
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
Low risk Although not stated, recurrence was calcu-
lated using the number of participants at
the start of the study
Withdrawals or dropouts?
All outcomes
High risk There were 244 participants available for
follow-up - 3 were missing from group 1,
and 2 were missing from group 2. No rea-
sons were given
Varma 1983
Methods This was a randomised controlled trial (UK, Department of Surgery)
Participants • 67 participants undergoing ingrown toenail surgery during a fixed 8-month
period (age and sex were not reported).
Interventions A: standard surgical wedge excision (35)
B: phenol wedge cauterisation (28)
Outcomes Outcomes of the trial
1) Symptomatic recurrence at least 6 months
2) Total recurrence after 6 months
3) Healing time (no standard deviation reported)
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details were given.
Allocation concealment (selection bias) Unclear risk It is not clear if sealed, consecutively num-
bered envelopes were used
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Varma 1983 (Continued)
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
Inclusion and exclusion criteria? High risk Neither inclusion nor exclusion criteria
were provided.
Outcome assessor blinded?
All outcomes
High risk This was not reported.
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
High risk There were 4/67 participants not included
in the final analysis
Withdrawals or dropouts?
All outcomes
High risk 4 participants were lost to follow up, but
no reasons were given
Wallace 1979b
Methods This was a randomised controlled trial (UK, Newcastle General Hospital)
Participants • 68 participants were included (age range = 10 to 73 years). Sex was not reported.
Interventions A: wedge resection (32)
B: gutter treatment (36)
Outcomes Outcomes of the trial
1) Failure of treatment after 6 to 15 months
2) Reoperation
3) Pain after 1 day
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk This was not reported.
Allocation concealment (selection bias) Unclear risk Third party independent randomisation
was not mentioned.
Selective reporting (reporting bias) Unclear risk This was unclear.
Other bias Unclear risk This was unclear.
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Wallace 1979b (Continued)
Inclusion and exclusion criteria? Low risk Quote: “Patients were selected using the
following criteria...”
Outcome assessor blinded?
All outcomes
Low risk Quote: “An independent observer exam-
ined the patients...”
Participant blinded?
All outcomes
High risk This was not reported.
Intention-to-treat?
All outcomes
Low risk All included participants were included in
the final analysis
Withdrawals or dropouts?
All outcomes
Low risk There were no withdrawals and/or drop-
outs.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Aksahal 2001 This was not a randomised controlled trial.
Andrew 1979 Participants were quasi-randomised (based on an odd or even number)
Arai 2004 This was not a randomised controlled trial.
Boberg 2002 The study was not about an ingrowing toenail.
Bossers 1992 Participants were quasi-randomised (based on their date of birth)
Bostanci 2007 Participants were quasi-randomised (based on their attendance at the surgery unit)
Burssens 1987 Participants were quasi-randomised (based on an odd or even number)
Cameron 1981 Participants were randomised (based on the stage of their ingrown toenail)
Córdoba-Fernandez 2008 The follow-up period was shorter than 1 month.
Foley 1994 There was no obvious distinction between onychocryptosis and onychogryphosis
Greig 1991b 2 studies were reported in the same paper. The second study was observational (not comparing inter-
ventions)
Herold 2001 Participants were quasi-randomised (based on their address).
Holt 1987 There was no obvious distinction between onychocryptosis and onychogryphosis
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(Continued)
Kocyigit 2005 Participants were quasi-randomised (based on their order of attendance)
Schütte 1980 This was a retrospective study.
Sykes 1988a This was not a trial (no comparison groups).
Tada 2004 This was not a randomised controlled trial.
Tait 1987 Participants were quasi-randomised (based on their date of birth)
Characteristics of studies awaiting assessment [ordered by study ID]
Altinyazar 2010
Methods The participants were randomly divided into 2 groups.
Participants • 44 participants with ingrown toenails were randomly divided into 2 groups.
Interventions Intervention
A: lidocaine with epinephrine
Control intervention
B: lidocaine without epinephrine
The plain lidocaine group (n = 22) underwent digital anaesthesia using 2% plain lidocaine, and the lidocaine with
epinephrine group (n = 22) underwent digital anaesthesia with 2% lidocaine with 1:100,000 epinephrine
In the postoperative period, the participants were evaluated for pain, drainage, and peripheral tissue destruction and
were followed for up to 18 months for recurrence
Outcomes Primary outcomes of the trial
1) Recurrence
Secondary outcomes of the trial
1) Pain
Notes -
Peyvandi 2011
Methods This was a prospective, randomised clinical trial.
Participants • 100 participants aged 12 to 50 with a stage III ingrowing toenail of hallux.
Interventions Intervention
A: wedge resection
Control intervention
B: gutter treatment
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Peyvandi 2011 (Continued)
Outcomes Primary outcomes of the trial
1) Recurrence
Secondary outcomes of the trial
1) Postoperative infection
Notes -
Tatlican 2009
Methods This was a randomised controlled trial.
Participants • 110 participants with 148 ingrowing nails (grade 2 to 3) (M/F = 54/56).
Interventions Intervention
A: 1 minute phenol
Control intervention
B: 2 and 3 minutes phenol
The participants were randomised to 3 groups for 1-, 2-, and 3-minute applications of phenol cauterisation of the
germinal matrix following surgical removal of ingrowing nails. Postoperative evaluations were made on days 2, 10,
16, 24, and 30 for pain, drainage, and tissue damage. Recurrences were recorded during a follow-up of 24 months
Outcomes Primary outcomes of the trial
1) Recurrence
Secondary outcomes of the trial
1) Postoperative pain
Notes The article was published in Turkish.
Zaba 2002
Methods This was a 3-arm randomised prospective study.
Participants • 34 participants
Interventions A: total nail edge excision
B: CO2 laser
C: Nd:YAG laser therapy
Outcomes Primary outcomes of the trial
1) Recurrence
Notes -
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Characteristics of ongoing studies [ordered by study ID]
ISRCTN32883274
Trial name or title Radio surgery versus 80% phenol for toe nail matrix ablation: a randomised comparison study
Methods This is a single-centre blinded randomised comparative trial
Participants Planned
• 60 participants
Inclusion criteria of the trial
• Participants aged 18 to 88 years with an ingrowing toenail or other nail conditions (involuted nail,
fungal infection, thickening or hypertrophy of the nail)
Interventions Intervention
A: radio surgery
Control intervention
B: matrix ablation with phenol
Outcomes Primary outcomes of the trial
1) Recurrence
2) Postoperative pain
3) Postoperative infection
4) Healing time
Secondary outcomes of the trial
1) Not provided at time of registration
Starting date 1st September 2005
Contact information Mr Ian Robinson
Podiatry
Dean Clarke House
Southernhay East
dhmail@doh.gsi.org.uk
Notes The status of the trial is completed.
NCT00641433
Trial name or title Topical Collagen-Silver Versus Standard Care Following Phenol Ablation of Ingrown Nails: A Randomized
Controlled Trial
Methods This is a randomised, single-blind, parallel study.
Participants Planned
• 80 participants
Inclusion criteria of the trial
• Participants aged 18 years and older with ingrown toenails defined as any incurvated nail border that
digs into the skin of the nail fold and causes pain and discomfort
Exclusion criteria of the trial
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NCT00641433 (Continued)
• Participants with immunocompromised states (chronic steroid use, diabetes mellitus, collagen vascular
disease, HIV infection)
Interventions Intervention
A: topical collagen-silver
Control intervention
B: standard care following phenol ablation of ingrown nails
Outcomes Primary outcomes of the trial
1) Healing time
Secondary outcomes of the trial
1) Days to recovery
Starting date 1st November 2005
Contact information David G Armstrong, DPM, PhD
Rosalind Franklin University
david.armstrong@rosalindfranklin.edu
847-578-8440
Notes Contact with the author was sought, but it was not successful
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D A T A A N D A N A L Y S E S
Comparison 1. Non-surgical procedures
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recurrence 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Gutter removal 3 days vs 2
weeks after treatment
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 2. Non-surgical vs surgical procedures
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recurrence 3 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Plastic gutter vs surgical
treatment
2 181 Risk Ratio (M-H, Random, 95% CI) 0.63 [0.47, 0.85]
1.2 Orthonyxia vs part matr
exc
1 102 Risk Ratio (M-H, Random, 95% CI) 0.89 [0.77, 1.04]
Comparison 3. Surgical procedures: Chem abln & surg vs surg proc
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recurrence 11 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 PNA + Ph vs wedge + surg
ME
5 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 PNA + Ph vs nail edge exc 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.3 PNA + Ph vs total avul 2 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.4 Ph + total avul vs total
avul + surg ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.5 PNA + Ph vs PNA + Surg
ME
2 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.6 PNA + sod vs total avul 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.7 PNA + ph vs PNA 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Pain of operation 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2.1 PNA + Ph vs wedge + surg
ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3 Postoperative infection 4 407 Risk Ratio (M-H, Random, 95% CI) 1.51 [0.53, 4.34]
3.1 PNA + Ph vs wedge + surg
ME
1 85 Risk Ratio (M-H, Random, 95% CI) 1.57 [0.37, 6.60]
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3.2 PNA + Ph vs nail edge exc 1 104 Risk Ratio (M-H, Random, 95% CI) 5.77 [0.74, 45.26]
3.3 PNA + Ph vs total avul 1 116 Risk Ratio (M-H, Random, 95% CI) 15.52 [0.91, 265.55]
3.4 Total avul + Ph vs total
avul + surg ME
1 31 Risk Ratio (M-H, Random, 95% CI) 0.17 [0.02, 1.25]
3.5 PNA + Ph vs PNA + surg
ME
1 71 Risk Ratio (M-H, Random, 95% CI) 1.15 [0.75, 1.77]
4 Postoperative haemorrhage 2 Risk Ratio (M-H, Random, 95% CI) Totals not selected
4.1 PNA + Ph vs wedge + surg
ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
4.2 PNA + Ph vs PNA + surg
ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
5 Postoperative analgesic use 2 Risk Ratio (M-H, Random, 95% CI) Totals not selected
5.1 PNA + Ph vs wedge + surg
ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
5.2 PNA + Ph vs PNA + surg
ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
6 Postoperative pain at 2 weeks
(VAS)
2 Mean Difference (IV, Random, 95% CI) Totals not selected
6.1 PNA + Ph vs PNA + surg
ME
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
6.2 PNA + Ph vs wedge + surg
ME
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
7 Participant satisfaction 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
7.1 Total avul + Ph vs total
avul + surg ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 4. Surgical procedures: Different types of surg proc
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recurrence 2 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Nail edge exc vs total avul 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 Wedge resec vs rad exc of
the nail fold
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.3 Wedge resec vs rotational
flap technique
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.4 Rad exc of the nail fold vs
rotational flap technique
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Participant satisfaction 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2.1 Nail edge exc vs total avul 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3 Postoperative infection 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
3.1 Nail edge exc vs total avul 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 5. Surgical procedures: Chem abln & partial avul vs chem abln & surg
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recurrence 3 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 PNA + Ph vs wedge + Ph 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 PNA + Ph vs PNA + sod 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.3 2 min sodium hydr vs 1
min sodium hydr
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Postoperative pain (yes/no) 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2.1 PNA + Ph vs wedge + Ph 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3 Postoperative pain intensity after
24h duration
1 Mean Difference (IV, Random, 95% CI) Totals not selected
3.1 PNA + Ph vs wedge + Ph 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 6. Surgical procedures: Wedge + electroful vs wedge + surg ME
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Postoperative pain at 2 weeks 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Wedge + electroful vs
wedge + surg ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Postoperative haemorrhage at 2
weeks
1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2.1 Wedge + electroful vs
wedge + surg ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 7. Postoperative procedures
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recurrence 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 PNA + surg ME vs PNA +
Ph
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Postoperative infection 3 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2.1 PNA + surg ME + AB vs
PNA + Ph + AB
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 Povidone-iodine with
paraff gauze vs hydrogel with
paraff gauze
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.3 Povidone-iodine with
paraff gauze vs paraff gauze
only
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
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2.4 Hydrogel with paraff
gauze vs paraff gauze only
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.5 Manuka honey dressing vs
paraff-impregn tulle gras
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3 Postoperative pain (VAS) 1 Mean Difference (IV, Random, 95% CI) Totals not selected
3.1 Manuka honey dressing vs
paraff-impregn tulle gras
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4 Healing time (days) 2 Mean Difference (IV, Random, 95% CI) Totals not selected
4.1 Povidone-iodine with
paraff gauze vs hydrogel with
paraff gauze
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4.2 Povidone-iodine with
paraff gauze vs paraff gauze
only
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4.3 Hydrogel with paraff
gauze vs paraff gauze only
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4.4 Manuka honey dressing vs
paraff-impregn tulle gras
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 8. Surgery plus postoperative treatment vs surgery
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recurrence 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 PNA + surg ME + AB vs
PNA + surg ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Postoperative infection 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2.1 PNA + surg ME + AB vs
PNA + surg ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 9. Surgery plus postoperative treatment vs phenol
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recurrence 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 PNA + surg ME + AB vs
PNA + Ph
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Postoperative infection 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2.1 PNA + surg ME + AB vs
PNA + Ph
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 10. Phenol plus postoperative treatment vs phenol
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recurrence 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 PNA + Ph + AB vs PNA +
Ph
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Postoperative infection 2 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2.1 PNA + Ph + 1wk AB after
vs PNA + Ph
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 PNA + Ph + 1wk AB after
vs PNA + Ph
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3 Healing time (weeks) 1 Mean Difference (IV, Random, 95% CI) Totals not selected
3.1 PNA + Ph + 1wk AB
afterwards vs PNA + Ph
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 11. Phenol plus postoperative treatment vs surgery
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recurrence 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 PNA + Ph + AB vs PNA +
surg ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Postoperative infection 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2.1 PNA + Ph + AB vs PNA +
surg ME
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 12. Preoperative treatment vs postoperative treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Healing time (weeks) 1 Mean Difference (IV, Random, 95% CI) Totals not selected
1.1 PNA + Ph + 1wk AB
advance vs PNA + Ph + 1wk
AB afterwards
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 13. Preoperative treatment vs surgery
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Postoperative infection 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 PNA + Ph + 1wk AB
advance vs PNA + Ph
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Healing time (weeks) 1 Mean Difference (IV, Random, 95% CI) Totals not selected
2.1 PNA + Ph + 1wk AB
advance vs PNA + Ph
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
Analysis 1.1. Comparison 1 Non-surgical procedures, Outcome 1 Recurrence.
Review: Interventions for ingrowing toenails
Comparison: 1 Non-surgical procedures
Outcome: 1 Recurrence
Study or subgroup Gutter remov 3 days Gutter remov 2 wks Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Gutter removal 3 days vs 2 weeks after treatment
Kim 2003 (1) 2/28 3/29 0.69 [ 0.12, 3.83 ]
0.01 0.1 1 10 100
Fav 3 days Fav 2 weeks
(1) n = number of patients
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Analysis 2.1. Comparison 2 Non-surgical vs surgical procedures, Outcome 1 Recurrence.
Review: Interventions for ingrowing toenails
Comparison: 2 Non-surgical vs surgical procedures
Outcome: 1 Recurrence
Study or subgroup Non-surgical Surgical
Risk
Ratio(Non-
event) Weight
Risk
Ratio(Non-
event)
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Plastic gutter vs surgical treatment
Perry 1984 (1) 6/11 15/102 20.2 % 0.53 [ 0.28, 1.02 ]
Wallace 1979b 16/36 5/32 79.8 % 0.66 [ 0.47, 0.91 ]
Subtotal (95% CI) 47 134 100.0 % 0.63 [ 0.47, 0.85 ]
Total events: 22 (Non-surgical), 20 (Surgical)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.36, df = 1 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 3.08 (P = 0.0021)
2 Orthonyxia vs part matr exc
Kruijff 2008 (2) 8/47 4/55 100.0 % 0.89 [ 0.77, 1.04 ]
Subtotal (95% CI) 47 55 100.0 % 0.89 [ 0.77, 1.04 ]
Total events: 8 (Non-surgical), 4 (Surgical)
Heterogeneity: not applicable
Test for overall effect: Z = 1.46 (P = 0.14)
0.2 0.5 1 2 5
Fav surgical Fav non-surgical
(1) n = number of nail edges
(2) n = number of toenails
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Analysis 3.1. Comparison 3 Surgical procedures: Chem abln & surg vs surg proc, Outcome 1 Recurrence.
Review: Interventions for ingrowing toenails
Comparison: 3 Surgical procedures: Chem abln % surg vs surg proc
Outcome: 1 Recurrence
Study or subgroup Chem abl+surg Surg Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph vs wedge + surg ME
Issa 1988 (1) 4/53 7/55 0.59 [ 0.18, 1.91 ]
Leahy 1990 (2) 11/39 12/46 1.08 [ 0.54, 2.17 ]
Morkane 1984 (3) 4/54 16/53 0.25 [ 0.09, 0.69 ]
van der Ham 1990 (4) 12/125 20/124 0.60 [ 0.30, 1.16 ]
Varma 1983 (5) 7/28 9/35 0.97 [ 0.41, 2.28 ]
2 PNA + Ph vs nail edge exc
Greig 1991a (6) 6/67 41/56 0.12 [ 0.06, 0.27 ]
3 PNA + Ph vs total avul
Greig 1991a (7) 6/67 59/81 0.12 [ 0.06, 0.27 ]
Sykes 1988c (8) 15/307 20/38 0.09 [ 0.05, 0.17 ]
4 Ph + total avul vs total avul + surg ME
Anderson 1990 (9) 6/14 10/17 0.73 [ 0.35, 1.50 ]
5 PNA + Ph vs PNA + Surg ME
Bos 2006 (10) 7/33 16/38 0.50 [ 0.24, 1.07 ]
Gerritsma-Bleeker 2002 (11) 7/29 7/34 1.17 [ 0.47, 2.95 ]
6 PNA + sod vs total avul
Shaath 2005 (12) 7/45 23/38 0.26 [ 0.12, 0.53 ]
7 PNA + ph vs PNA
Bos 2006 8/58 24/59 0.34 [ 0.17, 0.69 ]
0.01 0.1 1 10 100
Fav chem abl+surg Fav surg
(1) n = number of nails
(2) n = number of nail edges
(3) n = number of toes
(4) n = number of participants
(5) n = number of participants
(6) n = number of nails
(7) n = number of nail edges
(8) n = number of participants
(9) n = number of participants
(10) n = number of participants
(11) n = number of toenails
(12) n= number of participants
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Analysis 3.2. Comparison 3 Surgical procedures: Chem abln & surg vs surg proc, Outcome 2 Pain of
operation.
Review: Interventions for ingrowing toenails
Comparison: 3 Surgical procedures: Chem abln % surg vs surg proc
Outcome: 2 Pain of operation
Study or subgroup PNA+Ph Wedge + surg ME Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph vs wedge + surg ME
Leahy 1990 (1) 1/32 2/34 0.53 [ 0.05, 5.58 ]
0.01 0.1 1 10 100
Fav PNA+Ph Fav Wedge+surgME
(1) n = number of patients
Analysis 3.3. Comparison 3 Surgical procedures: Chem abln & surg vs surg proc, Outcome 3 Postoperative
infection.
Review: Interventions for ingrowing toenails
Comparison: 3 Surgical procedures: Chem abln % surg vs surg proc
Outcome: 3 Postoperative infection
Study or subgroup Phenol+surg Surg Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph vs wedge + surg ME
Leahy 1990 (1) 4/39 3/46 22.3 % 1.57 [ 0.37, 6.60 ]
Subtotal (95% CI) 39 46 22.3 % 1.57 [ 0.37, 6.60 ]
Total events: 4 (Phenol+surg), 3 (Surg)
Heterogeneity: not applicable
Test for overall effect: Z = 0.62 (P = 0.54)
2 PNA + Ph vs nail edge exc
Greig 1991a (2) 7/57 1/47 15.5 % 5.77 [ 0.74, 45.26 ]
Subtotal (95% CI) 57 47 15.5 % 5.77 [ 0.74, 45.26 ]
Total events: 7 (Phenol+surg), 1 (Surg)
Heterogeneity: not applicable
Test for overall effect: Z = 1.67 (P = 0.095)
3 PNA + Ph vs total avul
(5) n = number of participants
(Continued . . . )
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(. . . Continued)
Study or subgroup Phenol+surg Surg Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Greig 1991a (3) 7/57 0/59 10.1 % 15.52 [ 0.91, 265.55 ]
Subtotal (95% CI) 57 59 10.1 % 15.52 [ 0.91, 265.55 ]
Total events: 7 (Phenol+surg), 0 (Surg)
Heterogeneity: not applicable
Test for overall effect: Z = 1.89 (P = 0.058)
4 Total avul + Ph vs total avul + surg ME
Anderson 1990 (4) 1/14 7/17 16.3 % 0.17 [ 0.02, 1.25 ]
Subtotal (95% CI) 14 17 16.3 % 0.17 [ 0.02, 1.25 ]
Total events: 1 (Phenol+surg), 7 (Surg)
Heterogeneity: not applicable
Test for overall effect: Z = 1.74 (P = 0.082)
5 PNA + Ph vs PNA + surg ME
Bos 2006 (5) 19/33 19/38 35.8 % 1.15 [ 0.75, 1.77 ]
Subtotal (95% CI) 33 38 35.8 % 1.15 [ 0.75, 1.77 ]
Total events: 19 (Phenol+surg), 19 (Surg)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
Total (95% CI) 200 207 100.0 % 1.51 [ 0.53, 4.34 ]
Total events: 38 (Phenol+surg), 30 (Surg)
Heterogeneity: Tau2 = 0.76; Chi2 = 9.70, df = 4 (P = 0.05); I2 =59%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Chi2 = 9.21, df = 4 (P = 0.06), I2 =57%
0.001 0.01 0.1 1 10 100 1000
Fav phenol Fav surg
(1) n = number of nail edges
(2) n = number of participants
(3) n = number of participants
(4) n = number of participants
(5) n = number of participants
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Analysis 3.4. Comparison 3 Surgical procedures: Chem abln & surg vs surg proc, Outcome 4 Postoperative
haemorrhage.
Review: Interventions for ingrowing toenails
Comparison: 3 Surgical procedures: Chem abln % surg vs surg proc
Outcome: 4 Postoperative haemorrhage
Study or subgroup Phenol Surg Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph vs wedge + surg ME
Leahy 1990 (1) 1/39 1/46 1.18 [ 0.08, 18.24 ]
2 PNA + Ph vs PNA + surg ME
Arista 2006 (2) 2/17 5/16 0.38 [ 0.08, 1.67 ]
0.01 0.1 1 10 100
Fav phenol Fav surg
(1) n = number of nail edges
(2) n = number of participants
Analysis 3.5. Comparison 3 Surgical procedures: Chem abln & surg vs surg proc, Outcome 5 Postoperative
analgesic use.
Review: Interventions for ingrowing toenails
Comparison: 3 Surgical procedures: Chem abln % surg vs surg proc
Outcome: 5 Postoperative analgesic use
Study or subgroup Phenol Surg Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph vs wedge + surg ME
van der Ham 1990 (1) 25/125 68/124 0.36 [ 0.25, 0.54 ]
2 PNA + Ph vs PNA + surg ME
Arista 2006 (2) 12/20 8/17 1.28 [ 0.69, 2.37 ]
0.01 0.1 1 10 100
Fav Phenol Fav SurgME
(1) n = number of patients
(2) n = number of toenails
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Analysis 3.6. Comparison 3 Surgical procedures: Chem abln & surg vs surg proc, Outcome 6 Postoperative
pain at 2 weeks (VAS).
Review: Interventions for ingrowing toenails
Comparison: 3 Surgical procedures: Chem abln % surg vs surg proc
Outcome: 6 Postoperative pain at 2 weeks (VAS)
Study or subgroup Phenol + surg Surg
Mean
Difference
Mean
Difference
N Mean(SD)[mm] N Mean(SD)[mm] IV,Random,95% CI IV,Random,95% CI
1 PNA + Ph vs PNA + surg ME
Gerritsma-Bleeker 2002 (1) 29 2.3 (1.8) 34 1.9 (1.4) 0.40 [ -0.41, 1.21 ]
2 PNA + Ph vs wedge + surg ME
Morkane 1984 54 20.72 (25.56) 53 24.58 (28.96) -3.86 [ -14.22, 6.50 ]
-10 -5 0 5 10
Fav phenol Fav surg
(1) n = number of toenails
Analysis 3.7. Comparison 3 Surgical procedures: Chem abln & surg vs surg proc, Outcome 7 Participant
satisfaction.
Review: Interventions for ingrowing toenails
Comparison: 3 Surgical procedures: Chem abln % surg vs surg proc
Outcome: 7 Participant satisfaction
Study or subgroup Phenol Surg
Risk
Ratio(Non-
event)
Risk
Ratio(Non-
event)
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Total avul + Ph vs total avul + surg ME
Anderson 1990 (1) 14/14 16/17 0.40 [ 0.02, 9.12 ]
0.01 0.1 1 10 100
Fav phenol Fav surg
(1) n = number of patients
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Analysis 4.1. Comparison 4 Surgical procedures: Different types of surg proc, Outcome 1 Recurrence.
Review: Interventions for ingrowing toenails
Comparison: 4 Surgical procedures: Different types of surg proc
Outcome: 1 Recurrence
Study or subgroup SurgProc A SurgProc B Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Nail edge exc vs total avul
Greig 1991a (1) 41/56 59/81 1.01 [ 0.82, 1.24 ]
2 Wedge resec vs rad exc of the nail fold
Perry 1984 (2) 2/32 2/36 1.13 [ 0.17, 7.53 ]
3 Wedge resec vs rotational flap technique
Perry 1984 (3) 2/32 11/34 0.19 [ 0.05, 0.80 ]
4 Rad exc of the nail fold vs rotational flap technique
Perry 1984 (4) 2/36 11/34 0.17 [ 0.04, 0.72 ]
0.02 0.1 1 10 50
Fav SurgProc A Fav SurgProc B
(1) n = number of nails
(2) n = number of nails
(3) n = number of nails
(4) n = number of nails
Analysis 4.2. Comparison 4 Surgical procedures: Different types of surg proc, Outcome 2 Participant
satisfaction.
Review: Interventions for ingrowing toenails
Comparison: 4 Surgical procedures: Different types of surg proc
Outcome: 2 Participant satisfaction
Study or subgroup Nail edge exc Total avul
Risk
Ratio(Non-
event)
Risk
Ratio(Non-
event)
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Nail edge exc vs total avul
Greig 1991a (1) 23/47 27/59 0.94 [ 0.65, 1.36 ]
0.01 0.1 1 10 100
Fav nail edge exc Fav total avul
(1) n = patients
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Analysis 4.3. Comparison 4 Surgical procedures: Different types of surg proc, Outcome 3 Postoperative
infection.
Review: Interventions for ingrowing toenails
Comparison: 4 Surgical procedures: Different types of surg proc
Outcome: 3 Postoperative infection
Study or subgroup Nail edge exc Total avul Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Nail edge exc vs total avul
Greig 1991a 1/47 0/59 3.75 [ 0.16, 90.00 ]
0.01 0.1 1 10 100
Favours nail edge exc Favours total avul
Analysis 5.1. Comparison 5 Surgical procedures: Chem abln & partial avul vs chem abln & surg, Outcome 1
Recurrence.
Review: Interventions for ingrowing toenails
Comparison: 5 Surgical procedures: Chem abln % partial avul vs chem abln % surg
Outcome: 1 Recurrence
Study or subgroup PNA + Ph Wedge + Ph Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph vs wedge + Ph
Issa 1988 (1) 4/53 0/62 10.50 [ 0.58, 190.65 ]
2 PNA + Ph vs PNA + sod
Gem 1990a 6/74 11/83 0.61 [ 0.24, 1.57 ]
3 2 min sodium hydr vs 1 min sodium hydr
Gem 1990b 6/62 4/56 1.35 [ 0.40, 4.55 ]
0.002 0.1 1 10 500
Fav PNA+Ph Fav Wedge+Ph
(1) n = number of nail edges
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Analysis 5.2. Comparison 5 Surgical procedures: Chem abln & partial avul vs chem abln & surg, Outcome 2
Postoperative pain (yes/no).
Review: Interventions for ingrowing toenails
Comparison: 5 Surgical procedures: Chem abln % partial avul vs chem abln % surg
Outcome: 2 Postoperative pain (yes/no)
Study or subgroup PNA + Ph Wedge + Ph Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph vs wedge + Ph
Issa 1988 (1) 36/53 43/62 0.98 [ 0.76, 1.26 ]
0.01 0.1 1 10 100
Fav PNA+Ph Fav Wedge+Ph
(1) n = number of nail edges
Analysis 5.3. Comparison 5 Surgical procedures: Chem abln & partial avul vs chem abln & surg, Outcome 3
Postoperative pain intensity after 24h duration.
Review: Interventions for ingrowing toenails
Comparison: 5 Surgical procedures: Chem abln % partial avul vs chem abln % surg
Outcome: 3 Postoperative pain intensity after 24h duration
Study or subgroup PNA + Ph Wedge + Ph
Mean
Difference
Mean
Difference
N Mean(SD)[hours] N Mean(SD)[hours] IV,Random,95% CI IV,Random,95% CI
1 PNA + Ph vs wedge + Ph
Issa 1988 (1) 53 6.7 (13) 62 9.4 (13.5) -2.70 [ -7.55, 2.15 ]
-10 -5 0 5 10
Fav PNA+Ph Fav Wedge+Ph
(1) n = number of nail edges
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Analysis 6.1. Comparison 6 Surgical procedures: Wedge + electroful vs wedge + surg ME, Outcome 1
Postoperative pain at 2 weeks.
Review: Interventions for ingrowing toenails
Comparison: 6 Surgical procedures: Wedge + electroful vs wedge + surg ME
Outcome: 1 Postoperative pain at 2 weeks
Study or subgroup Wedge + electroful Wedge + surg ME Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Wedge + electroful vs wedge + surg ME
Flores 2006 (1) 7/21 7/17 0.81 [ 0.35, 1.86 ]
0.01 0.1 1 10 100
Fav wedge+electroful Fav wedge+surg ME
(1) n = number of nail edges
Analysis 6.2. Comparison 6 Surgical procedures: Wedge + electroful vs wedge + surg ME, Outcome 2
Postoperative haemorrhage at 2 weeks.
Review: Interventions for ingrowing toenails
Comparison: 6 Surgical procedures: Wedge + electroful vs wedge + surg ME
Outcome: 2 Postoperative haemorrhage at 2 weeks
Study or subgroup wedge + electroful wedge + surg ME Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Wedge + electroful vs wedge + surg ME
Flores 2006 (1) 4/21 3/17 1.08 [ 0.28, 4.18 ]
0.01 0.1 1 10 100
Fav wedge+electroful Fav wedge+surg ME
(1) n = number of nail edges
69Interventions for ingrowing toenails (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 7.1. Comparison 7 Postoperative procedures, Outcome 1 Recurrence.
Review: Interventions for ingrowing toenails
Comparison: 7 Postoperative procedures
Outcome: 1 Recurrence
Study or subgroup
PNA +
surg ME +
AB PNA + Ph + AB Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + surg ME vs PNA + Ph
Bos 2006 (1) 8/21 1/25 9.52 [ 1.29, 70.11 ]
0.005 0.1 1 10 200
Fav PNA+surg ME+AB Fav PNA+Ph+AB
(1) n = number of patients
Analysis 7.2. Comparison 7 Postoperative procedures, Outcome 2 Postoperative infection.
Review: Interventions for ingrowing toenails
Comparison: 7 Postoperative procedures
Outcome: 2 Postoperative infection
Study or subgroup Intervention A Intervention B Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + surg ME + AB vs PNA + Ph + AB
Bos 2006 (1) 10/21 12/25 0.99 [ 0.54, 1.82 ]
2 Povidone-iodine with paraff gauze vs hydrogel with paraff gauze
Dovison 2001 (2) 1/13 0/16 3.64 [ 0.16, 82.62 ]
3 Povidone-iodine with paraff gauze vs paraff gauze only
Dovison 2001 (3) 1/13 1/13 1.00 [ 0.07, 14.34 ]
4 Hydrogel with paraff gauze vs paraff gauze only
Dovison 2001 (4) 0/16 1/13 0.27 [ 0.01, 6.23 ]
5 Manuka honey dressing vs paraff-impregn tulle gras
McIntosh 2006 (5) 0/52 1/48 0.31 [ 0.01, 7.39 ]
(5) n = number of patients
(Continued . . . )
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(. . . Continued)
Study or subgroup Intervention A Intervention B Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
0.005 0.1 1 10 200
Favours A Favours B
(1) n = number of patients
(2) n = number of patients
(3) n = number of patients
(4) n = number of patients
(5) n = number of patients
Analysis 7.3. Comparison 7 Postoperative procedures, Outcome 3 Postoperative pain (VAS).
Review: Interventions for ingrowing toenails
Comparison: 7 Postoperative procedures
Outcome: 3 Postoperative pain (VAS)
Study or subgroup
Manuka
honey
dressing Paraff impregn. tulle
Mean
Difference
Mean
Difference
N Mean(SD)[mm] N Mean(SD)[mm] IV,Random,95% CI IV,Random,95% CI
1 Manuka honey dressing vs paraff-impregn tulle gras
McIntosh 2006 (1) 52 1.6 (1.22) 48 1.57 (1.3) 0.03 [ -0.47, 0.53 ]
-4 -2 0 2 4
Fav manuka honey Fav paraffin
(1) n = number of patients
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Analysis 7.4. Comparison 7 Postoperative procedures, Outcome 4 Healing time (days).
Review: Interventions for ingrowing toenails
Comparison: 7 Postoperative procedures
Outcome: 4 Healing time (days)
Study or subgroup Intervention A Intervention B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Povidone-iodine with paraff gauze vs hydrogel with paraff gauze
Dovison 2001 (1) 13 34.3 (4.8) 13 34.2 (7.7) 0.10 [ -4.83, 5.03 ]
2 Povidone-iodine with paraff gauze vs paraff gauze only
Dovison 2001 (2) 13 34.3 (4.8) 16 33.3 (6) 1.00 [ -2.93, 4.93 ]
3 Hydrogel with paraff gauze vs paraff gauze only
Dovison 2001 (3) 13 34.2 (7.7) 16 33.3 (6) 0.90 [ -4.22, 6.02 ]
4 Manuka honey dressing vs paraff-impregn tulle gras
McIntosh 2006 (4) 52 40.3 (18.21) 48 39.98 (25.42) 0.32 [ -8.41, 9.05 ]
-100 -50 0 50 100
Favours A Favours B
(1) n = number of patients
(2) n = number of patients
(3) n = number of patients
(4) n = number of patients
Analysis 8.1. Comparison 8 Surgery plus postoperative treatment vs surgery, Outcome 1 Recurrence.
Review: Interventions for ingrowing toenails
Comparison: 8 Surgery plus postoperative treatment vs surgery
Outcome: 1 Recurrence
Study or subgroup
PNA +
surg ME +
AB PNA + surg ME Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + surg ME + AB vs PNA + surg ME
Bos 2006 (1) 8/21 16/38 0.90 [ 0.47, 1.75 ]
0.01 0.1 1 10 100
Fav PNA+surg ME+AB Fav PNA+surg ME
(1) n = number of patients
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Analysis 8.2. Comparison 8 Surgery plus postoperative treatment vs surgery, Outcome 2 Postoperative
infection.
Review: Interventions for ingrowing toenails
Comparison: 8 Surgery plus postoperative treatment vs surgery
Outcome: 2 Postoperative infection
Study or subgroup
PNA +
surg ME +
AB PNA + surg ME Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + surg ME + AB vs PNA + surg ME
Bos 2006 (1) 10/21 19/38 0.95 [ 0.55, 1.65 ]
0.01 0.1 1 10 100
Fav PNA+surgME+AB Fav PNA+surgME
(1) n = number of patients
Analysis 9.1. Comparison 9 Surgery plus postoperative treatment vs phenol, Outcome 1 Recurrence.
Review: Interventions for ingrowing toenails
Comparison: 9 Surgery plus postoperative treatment vs phenol
Outcome: 1 Recurrence
Study or subgroup PNA + surg ME PNA + Ph Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + surg ME + AB vs PNA + Ph
Bos 2006 (1) 8/21 7/33 1.80 [ 0.76, 4.22 ]
0.01 0.1 1 10 100
Fav PNA+surgME+AB Fav PNA+Ph
(1) n = number of patients
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Analysis 9.2. Comparison 9 Surgery plus postoperative treatment vs phenol, Outcome 2 Postoperative
infection.
Review: Interventions for ingrowing toenails
Comparison: 9 Surgery plus postoperative treatment vs phenol
Outcome: 2 Postoperative infection
Study or subgroup
PNA +
surg ME +
AB PNA + Ph Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + surg ME + AB vs PNA + Ph
Bos 2006 10/21 19/33 0.83 [ 0.48, 1.41 ]
0.01 0.1 1 10 100
Fav PNA+surgME+AB Fav PNA+Ph
Analysis 10.1. Comparison 10 Phenol plus postoperative treatment vs phenol, Outcome 1 Recurrence.
Review: Interventions for ingrowing toenails
Comparison: 10 Phenol plus postoperative treatment vs phenol
Outcome: 1 Recurrence
Study or subgroup PNA + Ph + AB PNA + Ph Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph + AB vs PNA + Ph
Bos 2006 (1) 1/25 7/33 0.19 [ 0.02, 1.44 ]
0.01 0.1 1 10 100
Fav PNA+Ph+AB Fav PNA+Ph
(1) n = number of patients
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Analysis 10.2. Comparison 10 Phenol plus postoperative treatment vs phenol, Outcome 2 Postoperative
infection.
Review: Interventions for ingrowing toenails
Comparison: 10 Phenol plus postoperative treatment vs phenol
Outcome: 2 Postoperative infection
Study or subgroup
PNA + Ph +
1wk AB after PNA + Ph Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph + 1wk AB after vs PNA + Ph
Bos 2006 (1) 13/25 19/33 0.90 [ 0.56, 1.46 ]
2 PNA + Ph + 1wk AB after vs PNA + Ph
Reyzelman 2000 (2) 0/53 2/47 0.18 [ 0.01, 3.61 ]
0.005 0.1 1 10 200
Fav PNA+Ph + 1wk AB after Fav PNA + Ph
(1) n = number of patients
(2) n = number of patients
Analysis 10.3. Comparison 10 Phenol plus postoperative treatment vs phenol, Outcome 3 Healing time
(weeks).
Review: Interventions for ingrowing toenails
Comparison: 10 Phenol plus postoperative treatment vs phenol
Outcome: 3 Healing time (weeks)
Study or subgroup
PNA + Ph
+ AB after PNA + Ph
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 PNA + Ph + 1wk AB afterwards vs PNA + Ph
Reyzelman 2000 (1) 53 1.9 (0.7) 47 2 (0.8) -0.10 [ -0.40, 0.20 ]
-4 -2 0 2 4
Fav PNA + Ph+AB after Fav PNA + Ph
(1) n = number of patients
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Analysis 11.1. Comparison 11 Phenol plus postoperative treatment vs surgery, Outcome 1 Recurrence.
Review: Interventions for ingrowing toenails
Comparison: 11 Phenol plus postoperative treatment vs surgery
Outcome: 1 Recurrence
Study or subgroup PNA + Ph + AB PNA + surg ME Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph + AB vs PNA + surg ME
Bos 2006 (1) 1/25 16/38 0.10 [ 0.01, 0.67 ]
0.005 0.1 1 10 200
Fav PNA+Ph+AB Fav PNA+surgME
(1) n = number of patients
Analysis 11.2. Comparison 11 Phenol plus postoperative treatment vs surgery, Outcome 2 Postoperative
infection.
Review: Interventions for ingrowing toenails
Comparison: 11 Phenol plus postoperative treatment vs surgery
Outcome: 2 Postoperative infection
Study or subgroup PNA + Ph + AB PNA + surg ME Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph + AB vs PNA + surg ME
Bos 2006 (1) 13/25 19/38 1.04 [ 0.64, 1.70 ]
0.01 0.1 1 10 100
Fav PNA+Ph+AB Fav surg ME
(1) n = number of patients
76Interventions for ingrowing toenails (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 12.1. Comparison 12 Preoperative treatment vs postoperative treatment, Outcome 1 Healing
time (weeks).
Review: Interventions for ingrowing toenails
Comparison: 12 Preoperative treatment vs postoperative treatment
Outcome: 1 Healing time (weeks)
Study or subgroup PNA+Ph+1wkABadv PNA+Ph+1wkABafter
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 PNA + Ph + 1wk AB advance vs PNA + Ph + 1wk AB afterwards
Reyzelman 2000 (1) 48 2.3 (0.8) 53 1.9 (0.7) 0.40 [ 0.11, 0.69 ]
-2 -1 0 1 2
Fav PNA+Ph+1wkABadv Fav PNA+Ph+1wkABaft
(1) n = number of patients
Analysis 13.1. Comparison 13 Preoperative treatment vs surgery, Outcome 1 Postoperative infection.
Review: Interventions for ingrowing toenails
Comparison: 13 Preoperative treatment vs surgery
Outcome: 1 Postoperative infection
Study or subgroup
PNA + Ph +
1wk AB
advance PNA + Ph Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PNA + Ph + 1wk AB advance vs PNA + Ph
Reyzelman 2000 (1) 0/48 2/47 0.20 [ 0.01, 3.98 ]
0.01 0.1 1 10 100
Fav PNA+Ph+1wk ABadv Fav PNA + Ph
(1) n = number of patients
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Analysis 13.2. Comparison 13 Preoperative treatment vs surgery, Outcome 2 Healing time (weeks).
Review: Interventions for ingrowing toenails
Comparison: 13 Preoperative treatment vs surgery
Outcome: 2 Healing time (weeks)
Study or subgroup
PNA + Ph +
1wk AB
advance PNA + Ph
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 PNA + Ph + 1wk AB advance vs PNA + Ph
Reyzelman 2000 (1) 48 2.3 (0.8) 47 2 (0.8) 0.30 [ -0.02, 0.62 ]
-2 -1 0 1 2
Fav PNA+Ph+1wk ABadv Fav PNA + Ph
(1) n = number of patients
A P P E N D I C E S
Appendix 1. CENTRAL (Cochrane Library) search strategy
ingrowing toenail OR ingrown toenail OR ingrownnail ORunguis incarnatusORonychocryptosis ORonychogryphosisOR involuted
toenail OR embedded toenail OR eingewachsenen Zehnennagel OR ingrowing toenails OR ingrown toenails OR ingrown nails OR
involuted toenails OR embedded toenails OR eingewachsenen Zehnennagels OR ingrowing nail OR involuted nail OR embedded
nail OR eingewachsenen nagel OR ingrowing nails OR ingrown nails OR involuted nails OR embedded nails OR eingewachsenen
nagels
Appendix 2. MEDLINE search strategy
(Nails, Ingrown/ OR (“ingrowing toenail” OR “ingrown toenail” OR “ingrown nail” OR “unguis incarnatus” OR onychocryptosis OR
onychogryphosis OR “involuted toenail” OR “embedded toenail” OR “eingewachsenen Zehnennagel” OR “ingrowing toenails” OR
“ingrown toenails” OR “ingrown nails” OR “involuted toenails” OR “embedded toenails” OR “eingewachsenen Zehnennagels” OR
“ingrowing nail” OR “involuted nail” OR “embedded nail” OR “eingewachsenen nagel” OR “ingrowing nails” OR “ingrown nails”
OR “involuted nails” OR “embedded nails” OR “eingewachsenen nagels”).af ) AND (Randomized Controlled Trial/ OR (randomized
controlled trial OR randomized controlled trials OR random allocation ORdouble-blind methodOR single-blind method OR ((single
OR double OR treble OR triple) AND (mask OR masks OR masking OR blind OR blinds OR blinded)) OR “latin square” OR
placebos OR placebo* OR random* OR randomised controlled trial OR randomised controlled trials OR randomized active control
trials OR randomized active control trial OR randomised active control trials OR randomised active control trial OR RaCTORRaCTs
OR RCT OR RCTs).af )
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Appendix 3. EMBASE search strategy
(Ingrown Nail/ OR (“ingrowing toenail” OR “ingrown toenail” OR “ingrown nail” OR “unguis incarnatus” OR onychocryptosis OR
onychogryphosis OR “involuted toenail” OR “embedded toenail” OR “eingewachsenen Zehnennagel” OR “ingrowing toenails” OR
“ingrown toenails” OR “ingrown nails” OR “involuted toenails” OR “embedded toenails” OR “eingewachsenen Zehnennagels” OR
“ingrowing nail” OR “involuted nail” OR “embedded nail” OR “eingewachsenen nagel” OR “ingrowing nails” OR “ingrown nails”
OR “involuted nails” OR “embedded nails” OR “eingewachsenen nagels”).mp) AND (Randomized Controlled Trial/ OR (randomized
controlled trial OR randomized controlled trials OR random allocation ORdouble-blind methodOR single-blind method OR ((single
OR double OR treble OR triple) AND (mask OR masks OR masking OR blind OR blinds OR blinded)) OR “latin square” OR
placebos OR placebo* OR random* OR randomised controlled trial OR randomised controlled trials OR randomized active control
trials OR randomized active control trial OR randomised active control trials OR randomised active control trial OR RaCTORRaCTs
OR RCT OR RCTs).af )
Appendix 4. CINAHL search strategy
Nails, Ingrown/ OR (“ingrowing toenail” OR “ingrown toenail” OR “ingrown nail” OR “unguis incarnatus” OR onychocryptosis
OR onychogryphosis OR “involuted toenail” OR “embedded toenail” OR “eingewachsenen Zehnennagel” OR “ingrowing toenails”
OR “ingrown toenails” OR “ingrown nails” OR “involuted toenails” OR “embedded toenails” OR “eingewachsenen Zehnennagels”
OR “ingrowing nail” OR “involuted nail” OR “embedded nail” OR “eingewachsenen nagel” OR “ingrowing nails” OR “ingrown
nails” OR “involuted nails” OR “embedded nails” OR “eingewachsenen nagels” OR “ingrown toe nail” OR “ingrowing toe nail” OR
“ingrown toe nails” OR “ingrowing toe nails” OR “nail ingrowing”).mp
Appendix 5. Web of Science search strategy
ts=(“ingrowing toenail” OR “ingrown toenail” OR “ingrown nail” OR “unguis incarnatus” OR onychocryptosis OR onychogryphosis
OR “involuted toenail” OR “embedded toenail” OR “eingewachsenen Zehnennagel” OR “ingrowing toenails” OR “ingrown toenails”
OR “ingrown nails” OR “involuted toenails” OR “embedded toenails” OR “eingewachsenen Zehnennagels” OR “ingrowing nail” OR
“involuted nail” OR “embedded nail” OR “eingewachsenen nagel” OR “ingrowing nails” OR “ingrown nails” OR “involuted nails”
OR “embedded nails” OR “eingewachsenen nagels” OR “ingrown toe nail” OR “ingrowing toe nail” OR “ingrown toe nails” OR
“ingrowing toe nails” OR “nail ingrowing”)
WH A T ’ S N E W
Last assessed as up-to-date: 20 January 2010.
Date Event Description
15 February 2012 New search has been performed New search for studies. A substantial amount of new
information has been added in the form of 17 newly
included studies
15 February 2012 New citation required and conclusions have changed The title and scope of this review has been expanded
with a new team of authors
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H I S T O R Y
Protocol first published: Issue 2, 1999
Review first published: Issue 3, 1999
C O N T R I B U T I O N S O F A U T H O R S
Link with the editorial base and co-ordinating contributions from co-authors - JAHE
Searches - JAHE, JCvdW, and JS
Screening the abstracts - AKN and JAHE
Obtaining copies of the trials - JAHE and JCvdW
Assessing the full papers for inclusion - JAHE and BvW
Extracting data from the trials - JCvdW and BvW
Assessing the methodological quality - JAHE, JCvdW, and BvW
Entering the data into RevMan - JCvdW and BvW
Writing the text of the review - AKN, JAHE, JCvdW, and BvW
Consumer feedback on the synopsis - BvW
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
• Department of General Practice, Erasmus MC, Rotterdam, Netherlands.
External sources
• No sources of support supplied
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The Background, Objectives, Criteria, Search, and Methods sections of the protocol and first version of this review published in 1999
and 2003, respectively, were compared, and they remain the same.
This review is an update of the review by Rounding and Bloomfield titled ’Surgical treatments for ingrowing toenails’ (Rounding
2003). The title has been changed to ’Interventions for ingrowing toenails’ because this updated review has focused on all interventions
(surgical as well as non-surgical) for ingrowing toenails. We, therefore, amended the search strategies to incorporate this change.
Other changes are as follows:
• We excluded quasi-randomised studies (e.g. allocation by an odd or even number or date of birth) from this update.
• We added recurrence as a primary outcome.
• In the selection of studies, we divided studies into those we defined as follow-up period for cure (one month or more) and
recurrence (six months or more), and into secondary outcome measures (clinical judgment, participant satisfaction, complications,
improvement of symptoms).
• We used the risk ratio (RR) effects measure in this update, rather than the odds ratio (OR) that was used in the previous version
of this review. This is because risk and odds are different when events are common, and many of the outcomes of trials of skin
conditions are common events. This is in line with the Cochrane Skin Group’s editorial policy.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Combined Modality Therapy; Nails, Ingrown [prevention & control; ∗surgery]; Phenol [therapeutic use]; Randomized Controlled
Trials as Topic; Recurrence [prevention & control]; Toes
MeSH check words
Humans
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